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Selenium (Se) is a trace element that is incorporated into proteins in the form of the 21st 
amino acid, selenocysteine (Sec). Se supplementation was reported to have beneficial roles in 
prevention of cardiovascular and muscle disorders, cancer prevention and enhancement of the 
immune function. However, recent studies also showed that excessive dietary Se increases the 
risk of development of type 2 diabetes mellitus. Thus, better understanding of Se and 
selenoprotein functions is required. We used three approaches to address this problem. 
First, we used high-throughput sequencing to examine composition of the gut microflora 
in mice maintained on selenium-deficient, selenium-sufficient, and selenium-enriched diets, and 
then link information to selenoprotein expression and function. Our data indicate that Se 
supplementation affects both the composition of the intestinal microflora and the colonization of 
the gastrointestinal tract in germ-free mice, which in turn, influence the host selenium status and 
selenoproteome expression. 
Second, we characterized the phenotype of the 15 kDa selenoprotein (Sep15) knockout 
(KO) mice. Sep15 is a thioredoxin-like, endoplasmic reticulum (ER)-resident protein involved in 
the quality control of glycoprotein folding through its interaction with UDP-glucose:glycoprotein 
glucosyltransferase. We found that Sep15 KO mice develop nuclear cataracts at an early age. We 
 suggest that the cataracts resulted from improper folding status of lens proteins caused by Sep15 
deficiency.  
Third, we evaluated the role of Se and selenoproteins in naked mole rat (MR) 
Heterocephalus glaber, a rodent model of delayed aging due to its unusually long lifespan (>28 
years). Tissue imaging by X-ray fluorescence microscopy and direct analyses of trace elements 
revealed low levels of selenium in the MR tissues. Metabolic labeling of MR cells with 75Se 
followed by sequencing and assembly of the MR transcriptome revealed the loss of expression of 
glutathione peroxidase 1 (GPx1), whereas expression of other selenoproteins was preserved. 
Thus, MR is characterized by reduced utilization of selenium due to a specific defect in GPx1 
expression. 
Overall, the use of rodent models allowed us to obtain insights into interplay of dietary 
selenium, gut microbiota, and expression and function of several selenoproteins. 
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1.1 Selenoproteins: Identification and function  
The first identified selenoprotein was glutathione peroxidase 1 (GPx1) [1]. Initially 
isolated from erythrocytes, it was shown to protect hemoglobin from oxidative damage. 
Later, it was found to be highly dependent on selenium, which was incorporated into GPx1 
as the 21st amino acid, selenocysteine (Sec) [2, 3]. In comparison to cysteine (Cys), Sec has 
a lower pKa and is a stronger nucleophile [4]. Almost all known selenoproteins are 
enzymes with Sec in the active center. Sec insertion requires the presence of in-frame TGA 
codon and Sec insertion sequence (SECIS) element, a kink-turn RNA structure located in 
the 3’ UTRs of selenoprotein mRNAs. Biosynthesis of Sec occurs on its specific tRNA, 
tRNASer[Sec], which is initially charged with Ser. SECIS-binding protein 2 (SBP2) binds to 
the SECIS element in the RNA and recruits Sec-tRNASer[Sec] along with other factors 
involved in Sec insertion [5, 6]. Identification of the structure and conserved sequences of 
the SECIS element allowed development of computational programs for identification of 
selenoprotein genes in sequence databases [7-9]. The program SECISsearch was designed 
to recognize structural and thermodynamic parameters of SECIS elements [10]. By 
searching for SECIS elements, the in-frame TGA codon in the ORF and the presence of 
Cys orthologs of selenoproteins, it is possible to identify selenoprotein genes in genomic 
sequences. The human genome contains 25 selenoprotein genes (Table 1). Most of these 
proteins participate in maintaining cellular redox homeostasis, including three thioredoxin 
reductases (TRs), five glutathione peroxidases (GPx1), methionine sulfoxide reductase 
(MsrB1), and three thyroid hormone deiodinases (DIs). 
As is clear from Table 1, few selenoproteins have known functions. Besides TRs, 
GPxs, MsrB1, DIs, SelP, SelN and SPS2, the specific reactions catalyzed by selenoproteins 
are not known. However, conservation of selenoproteins among species and preservation 
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of the complicated biosynthesis pathway for their production indicate importance of this 
class of proteins. So far, the common feature of all selenoproteins with identified functions 
is their participation in the thiol-dependent reactions. This type of reactions is important in 
intracellular redox homeostasis and antioxidant defense. GPxs (and the N-terminal domain 
of SelP) are capable of reducing various peroxides [11, 12]. TRs and MsrB1 participate in 
the reduction of oxidized cysteine and methionine residues, respectively [13-16]. DIs 
catalyze removal of iodine (I) from the outer ring of the prohormone thyroxine (T4) 
yielding various forms of thyroid hormone [17, 18]. Sep15, SelM, SelH, SelS, SelN, SelT, 
SelW are less characterized, whereas almost studies have been done involving SelV, SelO, 
SelI and SelK. Most likely, all these proteins are oxidoreductases with Sec in the active 
site. More than half of mammalian selenoproteins are characterized by the thioredoxin like 
fold. Thioredoxin-like fold is a two-layer α/β/α sandwich structure that includes a 
conserved CXXC motif. In some cases, one of the Cys can be substituted with Ser or Thr. 
This fold is common for enzymes that catalyze formation or isomerization of disulfide 
bonds. At least 7 out of 25 selenoproteins (DI2, Sep15, SelK, SelM, SelN, SelS, and SelT) 
reside in the ER. ER enrichment with selenoproteins might indicate the roles of 
selenoproteins in ER associated processes, such as protein secretion/modification or ER 
associated degradation ERAD [19]. 
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Table 1. Mammalian selenoproteins: localization and functions 
Selenoprotein Localization Possible function ReReferences 
15 kDa selenoprotein 
(Sep15) 
ER -Trx-like fold 
-regulated by ER stress 
-interacts with UDP-glucose:glycoprotein 
glucosyltransferase 
-potentially involved in glycoprotein 
folding 
[20-23] 
Thyroid hormone 
deiodinase 1 (DI1) 
Plasma 
membrane 
-removes iodine from the outer ring of the 
T4 thyroid hormone to produce plasma T3 
-catalyzes deiodination and thus 
inactivation of T3 
[24, 25] 
Thyroid hormone 
deiodinase 2 (DI2) 
ER -converts T4 to T3 locally in tissues [26] 
Thyroid hormone 
deiodinase 3 (DI3) 
Plasma 
membrane 
-catalyzes deiodination of T4 thyroid 
hormone to T3 in peripheral tissues 
[25, 27] 
Glutathione 
peroxidase 1 (GPx1) 
Cytosol -GSH dependent detoxification of H2O2 
(enriched in liver, kidney, erythrocytes) 
[11] 
Glutathione 
peroxidase 2 (GPx2) 
Cytosol -GSH dependent detoxification of H2O2 
(enriched in epithelial tissues, including 
intestine and lung) 
[28, 29] 
Glutathione 
peroxidase 3 (GPx3) 
Plasma -GSH dependent detoxification of H2O2 
(synthetized predominantly in kidneys and 
secreted to plasma) 
[30] 
Glutathione 
peroxidase 4 (GPx4, 
PHGPx) 
Cytosol 
Mitochondria 
nucleus (testis 
specific) 
-has cytosolic, nuclear and mitochondrial 
isoforms 
-protects lipids from H2O2 mediated 
oxidation 
[31] 
Glutathione 
peroxidase 6 (GPx6) 
Cytosol 
 
-GSH dependent detoxification of H2O2 
 
(enriched in the olfactory epithelium) 
[29] 
Selenoprotein H 
(SelH) 
Nucleus -Trx-like fold 
-protects cells from H2O2, increases 
mitochondrial biogenesis and CytC 
production 
-AT-hook family protein. In response to 
redox changes facilitates synthesis of genes 
responsible for de novo glutathione 
synthesis and phase II detoxification 
[32-34] 
Selenoprotein I (SelI) Membrane unknown function [10] 
Selenoprotein K 
(SelK) 
ER -modulates Ca2+ influx that affects immune 
cell function 
[35] 
Selenoprotein M 
(SelM) 
ER -Trx-like fold 
-protects neurons from oxidative stress 
[36] 
Selenoprotein N ER membrane -expressed in skeletal muscle, heart, lung, [19, 37] 
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(SelN, SEPN1, 
SelN1) 
and placenta 
-controls redox state of the intracellular 
calcium-release channel (ryanodine 
receptor (RyR)), and therefore affects Ca2+ 
homeostasis  
-mutations in SelN gene cause congenital 
myopathy  
 
 
Selenoprotein O 
(SelO) 
Mitochondria unknown function [10] 
Selenoprotein P 
(SelP) 
Plasma -Se transport to peripheral tissues and 
antioxidant function 
[38-40] 
Selenoprotein R 
(SelR, MsrB1) 
Cytosol -reduces methionine-R-sulfoxide residues 
in proteins to methionine  
[16] 
Selenoprotein S 
(SelS, SEPS1, Tanis, 
VIMP, and 
SELENOS) 
ER -upregulated upon treatment with pro-
inflammatory cytokines and glucose 
deprivation 
-co-purifies with the ERAD complex   
[19, 41] 
SPS2 Cytosol -synthesis of selenophosphate  [42, 43] 
Selenoprotein T 
(SelT) 
ER and Golgi -Trx-like fold 
-redox regulation 
-plays a role in cell adhesion 
[44] 
Thioredoxin 
reductase 1 (TR1) 
Cytosol -controls redox state of thioredoxin 
-has 6 isoforms generated by alternative 
splicing 
[13, 45] 
Thioredoxin 
reductase 2 (TR2, 
TGR) 
Cytosol -contains glutaredoxin domain 
-catalyze a variety of reactions, specific for 
thioredoxin and glutaredoxin systems 
-expressed in spermatids  
[46] 
Thioredoxin 
reductase 3 (TR3) 
Mitochondria -reduces mitochondrial thioredoxin and 
glutaredoxin 2 
[47] 
Selenoprotein V 
(SelV) 
Cytosol -Trx-like fold 
-unknown function 
-expressed in spermatids 
[32] 
Selenoprotein W 
(SelW) 
Cytosol -Trx-like fold 
-unknown function 
-expressed in skeletal muscles 
[48] 
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1.2 Mouse models for studying selenoproteins 
Knockout (KO) and transgenic models can be used for evaluating protein functions 
as well as their impact on health. To evaluate selenoprotein functions, a number of mouse 
models were developed and characterized. Generally, all models can be divided into two 
groups. The first group includes animals lacking (or overexpressing) one or more 
individual selenoproteins. The second group includes various mouse models with altered 
selenoprotein biosynthesis pathway. These animals develop systemic selenoprotein 
deficiency. Both groups are discussed in the following sections.  
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1.2.1 Targeted removal of individual selenoproteins 
Several mouse models with targeted inactivation of one or more selenoproteins were 
developed and characterized [49, 50]. The overview is given in Table 2. So far, three 
selenoproteins were found to be essential: TR1, TR3 and GPx4. Knockout of cytosolic TR1 leads 
to embryonic death between E8.5 and E10.5 [51]. While the cardiomyocyte-specific TR1 KO mice 
developed normally, the neuronal system (NS) specific TR1 knockout caused severe neurological 
symptoms, such as ataxia and tremor [52]. These symptoms were the result of cerebellar 
hypoplasia, abnormal foliation, perturbed lamination in the cerebellum and reduced 
proliferation of granule cell precursors in cerebellum [52]. Disruption of TR1 in B and T cells did 
not affect viability and functions of immune cells [53]. Mitochondrial TR3 knockout induced 
embryonic lethality between E13.5 and E15.5. Compared to controls, embryos were smaller, 
developed anemia and showed high levels of liver apoptosis. NS-specific TR3 KO mice developed 
normally, without signs of neurodegeneration; however, the cardiomyocyte-specific TR3 KO 
mice died from heart failure within few hours of birth [54].  
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GPx4 is another essential enzyme: KO of this gene leads to embryonic lethality at E7.5 
[55]. GPx4 has cytosolic (cGPx4), nuclear (nGPx4) and mitochondrial (mGPx4) isoforms. All 
isoforms are synthesized from alternative translation initiation codons. nGPx4 expression is 
driven by its own testes-specific promoter, which lies inside the first intron of the cytosolic GPx4 
transcript [31]. To access the function of each isoform, several KO/transgenic mouse models 
were obtained. nGPx4 KO mice developed normally; neither testicular structure nor fertility 
were affected in these mice; however the delayed sperm chromatin condensation was observed 
[56]. The sequence between the two alternative translational initiation codons encodes a 
mitochondrial signal peptide. Thus, introduction of the in-frame stop codon between alternative 
translation initiation codons resulted in the disruption of the mGPx4 form without affecting 
expression of cGPx4. mGPx4 KO male mice were infertile [57]. These experiments revealed an 
essential role of mGPx4 in male fertility.  
KO of other GPxs did not affect viability and fertility. The major findings with GPx KO 
mice are summarized in Table 2. GPx1 KO mice did not show significant phenotypes; however, 
they were more susceptible to oxidative stress and viral myocardites [11, 58]. GPx2 is mainly 
expressed in epithelial tissues, and its disruption affects intestinal cells [59]. Double GPx1 and 
GPx2 KO mice are characterized by severe colitis when maintained on an atherogenic diet [60]. 
Recently, GPx3 KO mice were developed [61]. Even though no significant phenotype was 
observed, this model revealed the specific binding of GPx3 to the basement membranes of renal 
cortical proximal and distal convoluted tubules. 
Experiments designed to understand the function of selenoproteins in thyroid gave 
ambiguous results. Both general and liver-specific knockout of DI1, which is mainly 
expressed in thyroid and responsible for plasma T3 supply, did not lead to hypothyroidism, 
indicating a possible additional function in T3 degradation [62, 63]. DI2 is expressed in the 
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pituitary and is thought to be a T4 sensor that decreases TSH production, being part of the 
negative feedback loop for thyroid hormone production. DI2 KO mice showed pituitary 
resistance to T4 [64]. DI2 turned out to be important in conversion of T4 to T3 in 
peripheral tissues. T3 stimulation is critical for the development of the auditory functions 
[26, 65]. Lack of DI2 resulted in delayed cochlear differentiation that was the reason for 
the irreversible deafness of DI2 KO mice [65]. DI1/DI2 KO mice did not augment the 
phenotype of  D1 or D2 KO mice; it was rather the sum of each single KO [66]. DI3 is 
responsible for inactivation of T3. DI3 KO mice showed mild hypothyroidism, suggesting 
importance of T3 degradation for maintaining the thyroid hormone axis [67]. D3 KO mice, 
like DI2 KO mice, were characterized by impaired auditory function, but with different 
pathogenesis. Unlike DI2 KO, DI3 KO mice displayed accelerated cochlear differentiation, 
which also resulted in deafness. This finding suggests a protecting role of DI3 in cochlear 
development [68].  
Experiments with SelP KO mice suggested that the major function of SelP is the 
transport of Se from liver to peripheral tissues [69, 70]. SelP KO mice developed 
symptoms of general Se deficiency, such as ataxia, seizures and male infertility [71, 72]. 
Some of these symptoms could be rescued by dietary Se. Apparently, SelP KO mice is a 
particularly well suited model to study Se deficiency. The majority of SelP is synthesized 
in the liver. Analysis of the liver-specific Sec tRNASer[Sec] KO (liver Trsp KO) mice (these 
mice lack expression of all selenoproteins in the liver and will be discussed later in this 
chapter) showed decreased expression and activity of selenoproteins in peripheral tissues, 
which confirmed the transport function for the hepatic SelP [73]. The levels of Se in the 
brain remained unaffected in liver Trsp KO mice; also, these mice did not show any 
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neurological phenotype. These findings suggested another essential SelP function in the 
brain. Restoration of liver SelP expression in SelP KO mice restored Se transport and 
removed symptoms associated with Se deficiency [74]. Thus, hepatocyte-derived SelP 
provides the major Se supply for kidneys, testes and brain. However, under Se deficiency, 
overexpression of liver SelP was unable to rescue the phenotype of SelP KO mice, which 
indicates the importance of local SelP production to support selenoprotein biosynthesis 
under limiting Se conditions [74]. SelP consists of two parts. The N-terminal domain 
contains a conserved UxxC motif, which is part of the domain characterized by the 
thioredoxin-like fold [38]. The C-terminal part of SelP contains multiple Sec residues and 
is involved in providing Se for synthesis of other selenoproteins. Deletion of the C-
terminal region of SelP resulted in a milder phenotype compared to the KO of the entire 
protein. Overall, the C-terminus plays a critical role in Se transport [75].  
Recently, two additional KO models were described [76]. A KO of MsrB1 did not 
lead to strong phenotypes: the KO mice were viable and fertile. However, various tissues 
of MsrB1 KO mice were characterized by a decreased level of MsrA (methionine sulfoxide 
reductase specific for Met-SO) and increased levels of malondialdehyde, protein carbonyls, 
protein methionine sulfoxide, as well as higher levels of oxidized glutathione and reduced 
levels of free and protein thiols; all this indicates the persistent oxidative stress in MsrB1 
KO mice.  
Inactivation of the SelK gene also did not affect viability and fertility [35]. 
However, as a result of the receptor mediated Ca2+ flux, SelK KO mice showed 
compormised functions of the immune cells, including T cell proliferation, T cell and 
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neutrophil migration, and Fcγ receptor-mediated oxidative burst in macrophages, as well as 
higher susceptibility to viral infection.  
There are a number of selenoproteins, which are still poorly characterized, and 
which would benefit from developing of knockout mouse models. This list includes SPS2, 
SelI, SelO, SelS, SelT, SelV, SelW, and GPx6. 
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Table 2. Knockout of individual selenoprotein genes in mice 
Gene Phenotype References 
GPx1 -no gross phenotypes 
-susceptibility to oxidative stress and viral miocardites 
-acceleration of cardiac hypertrophy and dysfunction 
-reduced blood insulin and reduced islet β-cell mass in 
pancreatic tissue 
[11, 58] 
GPx2 -no gross phenotypes 
-increased apoptosis in colon crypt cells during Se 
deficiency 
[59] 
GPx1+GPx2 -microflora-dependent intestinal colitis 
-decreased levels of Paneth cells  
[60] 
GPx3   -no gross phenotypes [61] 
GPx4 -embryos die at E7.5  [55] 
TR1 -embryos die at between E8.5 and E10.5 [51] 
TR3 -embryos die at between E13.5 and E15.5 [54] 
DI1 -no gross phenotypes 
-increased iodine excretion 
[63] 
DI2 -pituitary resistance to T4 
-impaired thermogenic response to cold 
-at thermoneutral conditions, high fat diet induced glucose 
intolerance, and exacerbated hepatic steatosis 
-poor hearing, poorly differentiated sensory epithelium 
[26, 65] 
DI3 -reduced levels of circulating T4 and T3  
-retarded development  
-deafness with premature cochlear differentiation 
[67, 68] 
DI1+DI2 -mild hypothyroidism 
-the sum of DI1 KO and DI2 KO phenotypes 
[66] 
SelP -neuronal degeneration, leading to ataxia and seizures 
-reduced selenoprotein expression in peripheral tissues 
-male infertility 
[69-71] 
MsrB1 -no gross phenotypes 
-increased markers of oxidative stress 
[76] 
SelK -no gross phenotypes 
-impaired functions of immune cells 
[35] 
 
  
21 
 
1.2.2 Overexpression of selenoproteins in mice 
Besides selenoprotein gene KO, several studies described animals with 
overexpression of individual selenoproteins. One of the best such models is GPx- 
overexpressing mouse (GPx1oe). These mice were shown to develop hyperglycemia and 
hyperinsulinemia, and developed high levels of blood insulin and increased islet β-cell 
mass [77-79]. It should be noted that similar symptoms are observed in Type 2 diabetes. 
When maintained on high fat diet, these mice developed obesity and insulin resistance, 
unlike GPx1 KO mice, which had reduced insulin levels and decreased islet β-cell mass 
[78]. This phenotype of GPx1oe mice might be explained by insufficient ROS-mediated 
signaling in islet β-cells. In a different model of diabetes, expression of GPx1 had a 
beneficial effect. Here, overexpression of GPx1 in islet β-cell of the db/db mice alleviated 
hyperglycemia at an early age and completely reversed it by 20 weeks of age [80]. These 
results indicate the importance of controlled GPx1 expression for prevention of Type 2 
diabetes.    
Another group developed mice with transgenic overexpression of mitochondrial 
GPx4 (mGPx4) [81]. Compared to littermate controls, these mice developed attenuated 
cardiac dysfunction in response to ischemia/reperfusion injury. Overexpression of mGPx1 
reduced the levels of lipid peroxidation and slightly increased the activity of the electron 
transport chain (ETC) complexes I, III, and IV.  
Another example of overexpression of a selenoprotein in an animal model is 
overexpression of SelM in rats [82]. These rats showed a better response to oxidant 
treatment. When fed with high Se diet, transgenic rats showed altered ERK signal 
transduction in the brain, which was characterized by inhibition of the alpha/gamma-
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secretase activity and Tau protein phosphorylation. These observations suggest a possible 
protective role of SelM in Alzheimer's disease [83].    
1.3 Mouse models targeteing the selenoprotein biosynthesis 
pathway 
Inactivating a single selenoprotein in mouse can provide information about its 
function and phenotypes associated with its deficiency. However, targeting the Sec 
incorporation machinery allows modulation of expression of all selenoproteins. Many such 
models have been developed. 
1.3.1 Selenocysteine incorporating machinery  
In eukaryotic cells, Se incorporation is a complex multi-stage process [5, 6, 84, 85]. 
The overall pathway of Sec incorporation is illustrated in Fig 1. Sec is synthesized on its 
own tRNA, tRNA[Ser]Sec, which is the product of the Trsp gene. Initially, this tRNA is 
charged with Ser, forming Ser-tRNA[Ser]Sec. This reaction is catalyzed by seryl-tRNA 
synthetase (SerRS). Ser-tRNA[Ser]Sec  is further phosphorylated by phosphoseryl-
tRNA[Ser]Sec kinase (PSTK). The Se donor compound for the Sec biosynthesis, 
selenophosphate, is synthesized by selenophosphate synthetase 2 (SPS2). O-Phosphoseryl-
tRNA:selenocysteinyl-tRNA synthase (SecS) catalyze the pyridoxal phosphate dependent 
reaction which is resulted in Sec-tRNA[Ser]Sec formation. After that Sec-tRNA[Ser]Sec EFSec 
and SBP2 protein factors, and this supramolecular complex is translocated to nucleus [86]. 
SBP2 recognizes the SECIS element, which is located in the 3’-UTR of selenoproteins 
mRNAs. This complex supports the incorporation of Sec in response to the in-frame-UGA 
codon. There are several features, which are critical for proper function of the pathway: 1) 
As shown in Fig 1, SBP2 and EFSec shuttle between the nucleus and cytosol. This allows 
binding selenoprotein mRNAs in the nucleus and inhibition of the nonsense mediated 
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decay induced by in-frame stop codon [87]. 2) SPS2 is itself a selenoprotein, forming a 
positive feedback loop with the Se available in the cell [42]. 3) Recently, it was found that 
SPS2 can also synthesize thiophosphate, promoting incorporation of Cys in place of Sec. 
In mice maintained on the Se-deficient diet, insertion of Cys at UGA codon of TR1 
equaled that of Sec [88]. 4) Sec tRNA[Ser]Sec is a unique tRNA which undergoes multiple 
modifications, further regulating Sec incorporation. These modifications include 
isopentyladenosine modification at position 37 and methylcarboxymethyl-5’-uridine 
(mcm5U) at position 34. The last step in Sec tRNA[Ser]Sec maturation is the methylation of 
mcm5U, which is assisted by Secp43 and results in the formation of methylcarboxymethyl-
5’-uridine -2’-O-hydroxymethylribose (mcm5Um) [89]. This process is highly sensitive to 
the primary, secondary and tertiary structure of tRNA as well as to the overall Se status. 
mcm5U supports synthesis of “housekeeping” selenoproteins, such as GPx4, TR1 and TR3
 , whereas the methylated tRNA is needed for expression of “stress-related” 
selenoproteins, such as GPx1, GPx3, and MsrB1. This change in selenoproteins expression 
pattern is commonly observed during Se deficiency, but the precise molecular mechanism 
is unknown. 
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Figure 1. Schematic model for Sec biosynthesis and incorporation. See details in 
the text. Sec tRNA[Ser]Sec is charged with Ser, which is further phosphorylated by PSTK SPS2 
facilitate synthesis of the selenophosphate. SecS catalyze Sec formation. SECp43 catalyze 
methylation of the Sec tRNA[Ser]Sec at the A34 position. Protein factors, including SBP2 and 
EFSec binds to the SECIS element, located in the 3’UTR of the selenoprotein mRNA. After 
translocation to the cytosol protein factors facilitate interaction with the ribosome and Sec 
incorpotation.1.3.2 Mouse models  targeting the selenoprotein biosynthesis pathway 
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There are several ways to regulate efficiency of Sec incorporation. In order to 
modulate expression of selenoproteins, the easiest way is to change levels of dietary Se. To 
examine the effects of dietary Se on various health parameters, one can adjust Se 
concentration in rodent chow. For example, 0.1 ppm Se in rodent diet approximately 
corresponds to the human Recommended Dietary Allowance for adults, whereas 0.4 ppm 
Se may correspond to the diet supplemented with 200 µg Se/day, which is the dose most 
often used in the clinical trials involving Se [90-92]. This approach was successfully 
applied to examine Se function in diabetes [93], cancer [94], the immune response [95, 96], 
etc. The disadvantage of this approach is that, with change in dietary Se, the levels of low 
molecular weight Se compounds are also changed, which might itself influence certain 
pathways.   
1.3.3 Trsp transgenic models 
Stable expression of mutant Trsp was shown to severely affect selenoprotein 
biosynthesis by interfering with the Sec incorporation pathway by a dominant-negative 
mechanism. According to this hypothesis, two mouse models were generated. In the first 
model, A37 was substituted with G37 [97], and in the second, T34 was replaced with A34 
[98]. Both models lacked Um34; thus, expression of stress related selenoproteins was 
severely reduced, whereas expression of housekeeping selenoprotein genes was little 
affected. The effect of G37 transgene was tissue-specific: it was significant in liver and 
kidney, but low in tissues testes [97]. The G37 transgenic mice were studied for various 
health parameters. These mice were found to be more susceptible to viral infection [99], 
colon cancer [100] and X-ray damage [101]. Crossing of the G37 and C3/Tag mice 
provided a good model for studying the function of selenoproteins in prostate cancer. Such 
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mice were found to accelerate the development of prostatic epithelial neoplasia (PIN), 
suggesting a protecting role of selenoproteins during prostate cancer development [102]. 
G37 mice demonstrated enhanced muscles growth in experiments modeling the exercise 
overload. . These data correlated with initial activation of the insulin signaling pathway, 
which includes increased Akt and p70 phosphorylation [103]. Abnormal insulin signaling 
might be, in part, the reason for glucose intolerance and lead to a diabetes-like phenotype, 
that had been recently observed in G37 mice [93].  
1.3.4 Mouse models of Trsp knockout  
Another approach of inactivating selenoprotein function in mice is to target the 
Trsp gene. The complete KO of Trsp leads to embryonic lethality, but a conditional 
removal of Trsp is possible [104]. Development of the tissue-specific KO models helped to 
examine important functions of selenoproteins in heart and skeletal muscles, endothelial 
cells [105], skin [106], bone [107], neurons [106] and immune cells (macrophages, T cells 
and hematopoietic tissues) [108-110], but also more dispensable selenoprotein functions in 
liver [73, 111], mammary gland [104] and podocytes [112]. KO of Trsp in endothelial cells 
led to embryonic death at E14.5 due to necrosis of the central nervous system, erythrocyte 
immaturity and subcutaneous hemorrhage. Mice with the myocyte-specific Trsp KO died 
12 days after birth from acute myocardial failure [105]. Deletion of Trsp in skin resulted in 
runt phenotype, epidermal neoplasia, and abnormal development of the hair follicles. 
Altogether, these abnormalities induced weight loss and early death. Thus, selenoproteins 
have a function in maintenance of skin integrity [106]. Osteo-chondroprogenitor-specific 
Trsp KO mice showed multiple skeletal abnormalities, including growth retardation, 
abnormal epiphyseal plates, delayed ossification, and chondronecrosis of cartilage [107]. 
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The neuron-specific Trsp KO induced severe neurodegeneration in hippocampus and lead 
to the absence of certain interneurons [106] (similar to that that observed in the neuron-
specific GPx4 KO model). Besides, these mice showed degeneration of the Purkinje and 
granule cells that lead to cerebral hyperplasia. In several studies, Se modulated the immune 
response. To understand the function of selenoproteins in immune cells, T and B cell- 
specific Trsp KO mice were developed. The T-cell-specific Trsp KO had decreased pool of 
mature T-cells and impaired T-cell dependent antibody response. Lack of antioxidant 
enzymes caused extensive oxidative stress and weak proliferation in response to T-cell 
receptor stimulation [109]. Macrophage specific-Trsp KO mice showed impaired 
invasiveness, which might be explained by hyperproduction of ROS and altered expression 
of extracellular matrix proteins [108]. Ablation of the Trsp gene in hematopoietic tissues 
resulted in anemia, which led to an increased production of erythroid progenitors in bone 
marrow as well as to thymus atrophy [110]. The liver-specific Trsp KO induced expression 
of phase II enzymes, including various GSTs [113]. By preventing SelP synthesis and 
secretion, the liver-specific Trsp KO dramatically decreased plasma SelP. Thus, these mice 
showed symptoms of Se deficiency, which could be rescued by increased Se intake. 
Further characterization of these mice revealed elevated levels of apolipoprotein E (ApoE) 
in serum as well as plasma cholesterol [98]. The mammary gland-specific Trsp KO mice 
showed increased levels of p53 and decreased expression of BRCA1 tumor suppressor 
[104]. Overall, mouse models with conditional Trsp KO turned out to be a powerful tool 
for understanding functions of selenoproteins in tissues.    
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1.3.5 Knockout/transgenic mouse models 
An additional strategy to investigate the effect of transgene overexpression is to 
develop KO/transgenic animal models. In the case of selenoproteins, liver Trsp KO mice 
were crossed with G37 or A34 mice. In both cases, similar expression pattern of 
housekeeping selenoproteins was observed. Restoration of the housekeeping selenoprotein 
genes partially decreased elevated levels of ApoE and serum cholesterol that had been 
observed in the liver-specific Trsp KO. This research directly revealed the function of 
housekeeping selenoproteins in regulation of lipoprotein biosynthesis and metabolism [98].    
Another knockout/transgene mouse model was described in [114]. STAF (Sec 
tRNA gene transcription activating factor) is a transcription factor for several RNA PolII 
and RNA PolIII-dependent genes. In this study, the authors overexpressed Trsp lacking the 
STAF binding promoter region and afterwards removed the WT Trsp. Interestingly, 
removal of the STAF binding site did not affect Trsp levels in heart and testis, but showed 
severe reduction of the transgene in liver, kidney, lung, spleen, and brain. Moreover, 
methylation of Trsp at A34 was significantly decreased, and expression of stress-related 
selenoproteins was reduced. These mice demonstrated the neurological phenotype similar 
to that of SelP KO mice. These findings indicated the importance of the STAF binding 
region in regulation of Sec tRNASer[Sec] expression and its proper modification.  
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CHAPTER 2  
Dietary selenium affects host selenoproteome expression by influencing the gut 
microbiota 
 
 
 
 
 
 
Note: The results described in this chapter have been published. 
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J., Legge, R., Benson, A.K., Hatfield, D.L. & Gladyshev, V.N. (2011) "Dietary selenium 
affects host selenoproteome expression by influencing the gut microbiota", The FASEB 
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2.1 Abstract 
Colonization of the gastrointestinal tract and composition of the microbiota may be 
influenced by components of the diet, including trace elements. To understand how 
selenium regulates the intestinal microflora, we used high-throughput sequencing to 
examine the composition of gut microbiota of mice maintained on selenium-deficient, 
selenium-sufficient, and selenium-enriched diets. The microbiota diversity increased as a 
result of selenium in the diet. Specific phylotypes showed differential effects of selenium, 
even within a genus, implying that selenium had unique effects across microbial taxa. 
Conventionalized germ-free mice subjected to selenium diets gave similar results and 
showed an increased diversity of the bacterial population in animals fed with higher levels 
of selenium. Germ-free mice fed selenium diets modified their selenoproteome expression 
similar to control mice but showed higher levels and activity of GPx1 and MsrB1 in the 
liver, suggesting partial sequestration of selenium by the gut microorganisms, limiting its 
availability for the host. These changes in the selenium status were independent of the 
levels of other trace elements. The data show that dietary selenium affects both 
composition of the intestinal microflora and colonization of the gastrointestinal tract, 
which, in turn, influence the host selenium status and selenoproteome expression. 
2.2 Introduction 
Intestinal microorganisms play an important role in human physiology by 
regulating such processes as maturation and proliferation of the intestinal cells, food 
digestion, protection from pathogenic bacteria, and modulation of the mucosal immune 
response [115, 116]. Growing evidence also links imbalances in the composition of the gut 
microbiota to complex diseases, including colon cancer, obesity, inflammatory bowel 
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disease, and Crohn’s disease [117-122], suggesting that dietary interventions affecting the 
gut microbiota hold substantial promise as alternative approaches to influence human 
health [123]. One of the main strategies to regulate the gut microbiota through diet is the 
use of prebiotics, which are defined as nondigestible food ingredients that beneficially 
affect the host by selectively stimulating the growth and/or activity of one or a limited 
number of bacterial species in the colon [124]. Because prebiotics promote growth of a 
select group of microorganisms, other strategies must also be examined, including those 
that can selectively inhibit or promote growth of species associated with complex diseases. 
One such strategy may involve modulation of dietary trace elements. Gut 
microorganisms, like their hosts, are expected to be sensitive to trace elements. Some 
species require trace elements such as Se for normal metabolic functions, whereas these 
same elements can be toxic to other microorganisms, even at very low concentrations [125, 
126]. Therefore, changes in dietary trace elements may modulate the composition of 
intestinal microbiota. For example, reducing dietary iron (Fe) caused an increase in the 
growth of certain organisms in the small intestine, including anaerobes, microaerophiles, 
lactobacilli, and enterococci. On the other hand, an increase in dietary Fe suppressed 
anaerobes, presumably due to elevated oxidative stress [127]. However, the effect of other 
trace elements on intestinal microbiome is largely unknown. Se is an essential trace 
element that plays an important role in human health. In particular, it is required for 
biosynthesis of selenoproteins, which participate in the regulation of cellular redox 
homeostasis, protection from oxidative stress, immune response, cancer chemoprevention, 
and other processes [128]. Supplemental Se has been shown to be effective in decreasing 
incidence and mortality from several forms of cancer, including colon cancer, in both 
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mouse models and humans [100]. On the other hand, some selenoproteins may promote 
carcinogenesis, so the role of Se in cancer development is complex. 
We hypothesized that Se supplementation may modify composition of mouse 
microbiota. At the same time, microflora may sequester Se, thus limiting its availability to 
the host [129]. A better understanding of these interactions might reveal novel aspects of 
the influence of the microbiota on metabolism of the host. The purpose of the current study 
was to characterize the impact of Se diets on microbiota and the role of microbiota in 
influencing Se status of the host. 
2.3 Experimental Procedures 
Animals and feeding protocols. The diets used in the study, including 0-, 0.1-, 
0.4-, and 2.25-µg/g (ppm) Se diets, were purchased from Harland TekLad (Madison, WI, 
USA). As described previously [94], these diets are based on the Torula yeast Se-deficient 
diet. Se was provided in the form of sodium selenite; 0, 0.1, 0.4, and 2.25 ppm Se indicate 
the added amounts of Se. In the first experiment, 4-wk-old C57BL/6J male mice 
(purchased from Jackson Laboratory, Bar Harbor, ME, USA) were subjected to these 4 Se 
diets (8 mice/group). Ten weeks later, feces were collected and frozen until further 
analysis. In the second experiment, 10-wk-old germ-free Swiss Webster male mice were 
subjected to 3 diets: 0, 0.1, and 0.4 ppm Se. One cohort of these animals (5 mice/group) 
was maintained germ free, and these mice are designated germ-free (GF) mice. Another 
group (5 mice/group) was placed in a similar germ-free environment, but it was 
conventionalized with the microflora prepared from the intestine of C57BL/6J mice used 
in the previous experiment. These mice are designated as conventionalized (CV) mice. 
Both groups of animals were maintained on the same Se diets, in the same facility and at 
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the same time, under specific pathogen-free conditions with 12-h light-dark cycle. All 
animal experiments were approved by the University of Nebraska–Lincoln (UNL) 
Institutional Animal Care and Use Committee. 
Sample preparation. After 8 wk on the diets, feces from CV mice were collected 
and frozen until further analysis. Then, GF and CV mice were sacrificed; their tissues were 
collected and immediately frozen in liquid nitrogen. For Western blot analysis and activity 
measurements, tissues were homogenized in PBS supplemented with protease inhibitor 
cocktail (Sigma, St. Louis, MO, USA). Cellular debris was removed by centrifugation 
at13,000 rpm for 15 min at 4°C, and protein concentration was determined with the 
Bradford assay. 
DNA isolation and pyrosequencing. Total DNA was extracted from the fecal 
pellets of 8 mice/feeding group, as described previously [130]. The 16S rRNA gene was 
amplified using modified F8 and R357 universal primers. These 16S rRNA PCR products 
were then subjected to pyrosequencing on a Roche/454 GS-FLX instrument (Roche, Basel, 
Switzerland) in the UNL Core for Applied Genomics and Ecology. The PCR products 
from each animal were bar coded and then mixed into a single sequencing run on the 
machine, so as to generate 2000 reads/animal. Taxonomy-dependent analysis was first 
performed using the naive bayesian Classifier algorithm of the Ribosomal Database Project 
(RDP; Michigan State University, East Lansing, MI, USA). Phylotypes were determined at 
97% cutoffs using CD-Hit, and representative sequences were searched against the RDP 
database using SeqMatch. Statistical analyses were performed on taxonomic groups from 
Classifier and CD-Hit phylotypes by normalizing the number of reads per taxon or 
phylotype by the total number of reads for a given animal. These normalized proportions 
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were then tested for statistical significance by ANOVA. For rarefaction analysis, 
phylotypes were assigned using the RDP pipeline (Aligner complete linkage clustering) 
and rarified using the Web-based rarefaction tools. 
Western blot analyses and activity assays. Expression of selenoproteins GPx1, 
SelP and MsrB1 was analyzed by Western blots with polyclonal antibodies specific for 
these proteins. To assay for GPx1 activity, a glutathione peroxidase kit was used (Sigma). 
MsrB activity was measured in an HPLC assay. Briefly, 200 µg of total protein was added 
to a reaction mixture (100 µl), the mixture was kept at 37°C for 30 min in the presence of 
20 mM DTT, and 200 µM dabsyl-methionine-R-sulfoxide was added. After stopping the 
reaction by adding 200 µl acetonitrile, it was centrifuged at 4°C for 15 min at 13,000 rpm, 
and the supernatant (50 µl) was injected onto a C18 column (Zorbax Eclipse XDB-C18; 
Agilent Technologies, Santa Clara, CA, USA) to quantify the resulting dabsylated 
methionine. 
RNA isolation and quantitative PCR. To analyze for SelP mRNA expression in 
the liver, total RNA was isolated by TriZOL extraction (Invitrogen, Carlsbad, CA, USA), 
according to the manufacturer’s instructions. Genomic DNA was removed using a DNA 
removal kit (Ambion, Austin, TX, USA). RNA concentration was measured 
spectrophotometrically, and cDNA was obtained with SuperScript III Reverse 
Transcriptase (Invitrogen). Real time PCR was performed using a Fast SYBR Green 
Master Mix (Applied Biosystems, Foster City, CA, USA). Primer sequences for the SelP 
expression analysis were as described previously [131]: 5’- 
CCTTGGTTTGCCTTACTCCTTCC-3’ and 5’-TTGTTGTGGTGTTTGTGGTGG-3’. 
SelP mRNA expression level was normalized to that of actin mRNA. 
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Analyses of trace elements. To measure Se content in biological materials, we 
applied quantitative inductively coupled plasma mass spectroscopy (ICP-MS). Tissue 
extracts were digested with the mixture of 15% nitric acid and 15% hydrogen peroxide for 
2 h at 70°C. After digestion, samples were diluted 10x with PBS, and the internal standard 
(gallium) was added to a final concentration of 50 ppb. Each sample was analyzed 3 times 
and in triplicate. The ICP-MS analysis was performed at the UNL Redox Biology Center 
spectroscopy core facility, using 7500 Agilent Technologies and Elemental Scientific 
(Omaha, NE, USA) SC4 autosampler instruments operating with a collision. 
2.4 Results 
Dietary Se regulates composition of the intestinal microbiota. To assess the 
effect of dietary Se on the composition of mouse microbiota, 2-mo-old male C57BL/6J 
mice were subjected to a Se-deficient diet and diets supplemented with 0.1, 0.4, or 2.25 
ppm of Se in the form of sodium selenite. Previously, these diets were shown to modulate 
selenoprotein expression [94]. The expected (i.e., based on what is known about regulation 
of selenoprotein expression) changes in selenoprotein levels are shown schematically in 
Fig 2A. After 8 wk on the diets, the Se status of mice was examined by analyzing the 
levels of SelP, the main selenoprotein in plasma of mammals. SelP decreased dramatically 
in mice fed the Se-deficient diet, whereas, as expected, the differences in SelP levels 
among mice fed other diets were minimal (Fig 2B). Feces from animals in the Se diet 
groups were collected, and the gut microbiota were examined by pyrosequencing of 16S 
ribosomal RNA tags at a sequencing depth of ~2000 reads/animal. Using a threshold of 
97% for phylotype assignment, rarefaction analysis of the data pooled by Se diet group 
showed a significant effect of Se deficiency on the numbers of phylotypes that were 
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detected. Overall, Se in the diet increased the diversity of the microbiota (Fig 3A). This Se-
induced increase was similar at all supplementation levels. To examine the effects of Se on 
major taxonomic groups of the microbiota, the proportions of taxa at the phylum, class, 
and order level from Classifier data were analyzed by ANOVA. No significant differences 
were observed on the relative proportions of major taxonomic groups (data not shown). 
The effects on specific phylotypes were then examined using 97% CD-Hit clusters. 
ANOVA identified several phylotypes showing significant effects of diet (Fig 3B). 
Remarkably, there were differential effects on related taxa. For example, some phylotypes 
belonging to the class Bacteriodales showed increases in response to Se (e.g., 
Porphyromonadaceae phylotypes 1 and 3, Tanerella phylotype 2), whereas others, such as 
Alistipes phylotype 1 and Parabacteroides phylotype 3 declined. Relative to absolute 
abundance, the decline in Parabacteroides in response to Se in the diet was by far the most 
significant effect on the microbiota. As with many phylotypes in the Bacteriodetes, several 
of the Firmicutes also showed modest effects in response to Se, including phylotypes 
within the Clostridia and Erysipelotrichi. 
Se supplementation influences bacterial colonization of the gastrointestinal 
tract. To determine whether the microbiota have a significant effect on the physiological 
distribution of dietary Se, GF Swiss Webster mice were treated with the same 3 Se diets (0, 
0.1, and 0.4 ppm Se), except that these diets were sterilized. One cohort of these animals 
was maintained GF, while the gut microbiota was reestablished in the other cohort using 
fecal materials from the CV C57BL/6J animals used in the previous experiment. Before 
and after 8 wk of diet treatment and conventionalization, SelP levels were examined in 
plasma, and fecal samples were taken at the end of the experiment and subjected to the 
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analysis of microbiota. Western blots revealed undetectable SelP in all mice fed the Se-
deficient diet, whereas little difference was observed between the 0.1- and 0.4-ppm Se 
groups (Fig 2C). Thus, dietary Se affects selenoprotein expression independent of GF, CV, 
or colonization conditions in mice. Similar to the conventional animals, pyrosequencing of 
the microbiota from conventionalized GF animals showed effects on the microbiota. Most 
notable was an increase in the overall diversity of the microbiota (Fig 3A). While the 0.4-
ppm diet in the conventionalized GF animals showed significantly increased diversity, the 
0.1-ppm diet did not. Statistical analysis of the phylotype abundances in the 
conventionalized GF animals showed that several phylotypes were affected by dietary Se 
(Fig 3B). In general, these phyla belonged to the same taxonomic groups as those affected 
in the conventional animals, including phylotypes related to Tanerella and 
Porphyromonadaceae. As in the conventional animals, these phylotypes showed 
differential effects, with some being stimulated by Se and others significantly decreasing. 
Likewise, one of the phylotypes belonging to the Clostridiales showed significant increases 
in response to Se in the conventional animals, but another phylotype was significantly 
reduced in response to dietary Se in the conventionalized GF animals. Collectively, our 
results show that dietary Se affects the overall diversity of the microbiota and has 
differential effects on specific taxonomic groups, even in related taxa. These effects were 
observed whether the microbiota was obtained naturally or by conventionalizing GF 
animals. 
Microbial colonization affects the levels and activities of selenoproteins of the 
host. Gastrointestinal microbiota was recently shown to affect Se status and selenoprotein 
expression in mice [129]. In that study, conventional FVN/NHanTMHsd maintained for 5 
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weeks on Se-deficient and Se-adequate diets showed reduced GPx and/or thioredoxin 
reductase 1 (TR1) activities in plasma, liver, and/or intestine under Se limiting conditions, 
when compared to the corresponding GF group. In our study, we analyzed the status of 
stress-related selenoproteins, GPx1 and MsrB1, in tissues of GF mice in comparison with 
those in CV mice, which served as controls, thus allowing us to directly examine the effect 
of gut colonization on the selenoprotein status of animals. In this experiment, GF and CV 
mice were subjected, in parallel, to 0-, 0.1-, and 0.4-ppm Se diets, and expression levels 
and activities of GPx1 and MsrB1 were analyzed in liver and kidney. Both GF and CV 
mice showed similar patterns of selenoprotein regulation. Their expression in mice on the 
0-ppm Se diet was dramatically lower, and we also observed differences in selenoprotein 
expression between 0.1- and 0.4-ppm Se diets. Selenoenzyme activities paralleled the 
expression patterns. Total GPx activity (GPx1 is the main GPx in liver and kidney of mice; 
thus, this activity largely corresponds to the activity of GPx1), and the total MsrB activity 
(MsrB1 is the main MsrB in liver and kidney) was decreased several fold in the 0-ppm Se 
group compared to the 0.1-ppm Se group, whereas the 0.4-ppm Se group showed a 
statistically significant increase over the 0.1-ppm Se group. This is consistent with the 
previous findings that expression of GPx1 and MsrB1 is maximized at ~0.15 ppm Se in the 
diet [131]. However, we were particularly interested in the effect of gut colonization on the 
regulation of selenoprotein expression (Fig 4). Indeed, within the 0.1-ppm Se groups, we 
observed higher GPx1 expression in liver and kidney, and higher GPx activity in kidneys 
of GF mice, compared to CV mice. In addition, within the 0.4-ppm Se groups, higher 
GPx1 expression and activity were observed in kidneys, and we also found higher MsrB 
activity in liver and kidneys of GF mice. In the 0-ppm Se group, we did not observe 
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differences between GF and conventionalized mice, probably because of low expression 
and activity of selenoproteins, which approached background levels. Overall, there was a 
clear pattern wherein conventionalization of mice decreased expression and activity of 
stress-related selenoproteins in liver and kidney. 
Gut colonization and SelP levels in plasma. Mouse SelP contains 10 
selenocysteine residues and is highly expressed in hepatocytes. This secreted protein 
transports Se from liver to other organs and was also suggested to serve an antioxidant 
function [38]. Unlike other selenoproteins, SelP showed a trend toward increased levels in 
CV mice; at least in the mice fed 0.1 ppm Se, as examined by Western blots (Fig 5A). 
However, its mRNA expression in the liver did not differ between GF and CV mice (Fig 
5B). We also examined Se levels in plasma in GF and CV mice (Fig 5C). Whereas the 0-
ppm Se group showed several fold lower Se levels, there were no statistically significant 
differences within each dietary group between GF and CV mice. 
Influence of Se status and gut colonization on other trace elements. The 
intestinal microbiota may be sensitive to changes in trace element levels, and, in turn, gut 
colonization may influence host trace element status, either through competition for certain 
elements or by modifying the processes of food absorption or digestion. Using ICPMS, we 
analyzed concentrations of several trace elements in CV and GF mice subjected to the 3 Se 
diets in liver, kidney, spleen, brain, and testes (Fig 6). Se levels in liver, kidney, and spleen 
were sensitive to dietary Se, whereas its concentration in brain and testes did not differ 
with changes in the Se dietary levels. Also, we found no difference in the Se levels 
between GF and CV mice. Analysis of other trace elements, including Mn, Fe, Zn, Mo, 
Cu, and As, did not reveal statistically significant differences between Se diets. Cd levels 
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in the liver were higher in GF mice regardless of the diet, suggesting a possible role of the 
gastrointestinal microbiotain assisting in detoxification of this element. 
2.5 Discussion 
Intestinal microbiota is sensitive to dietary Se status. Our results indicate that 
dietary Se can affect both the composition of the existing microbiota and establishment of 
gastrointestinal microflora. Particularly, in both experiments, the strongest effect was 
observed within genus Parabacteroides of the phylum Bacteriodetes, which demonstrated 
the opposite correlation with dietary Se supplementation. This finding might be explained 
by the use of Se by various microorganisms and Se toxicity to certain organisms. We also 
observed differential effects of Se across multiple phylotypes belonging to the phylum 
Bacteriodetes. It is possible that the niches vacated by the effect of Se on Parabacteroides 
were filled by other phylotypes within related taxonomic groups. The fact that multiple 
groups showed increases while fewer groups, in general, showed decreases is consistent 
with the overall effect of Se on increasing diversity of the microbiota. The differential 
sensitivity of various microorganisms to dietary Se is likely due to differences in their 
ability to uptake, store, use, and remove Se from the cell. In particular, the gut microbiota 
may sequester Se for expression of its own selenoproteins. About one quarter of all 
bacteria expresses selenoproteins, and, therefore, they require Se for optimal growth. For 
example, Escherichia coli has 3 selenoproteins. The number of selenoproteins in bacteria 
varies from 0 to 57. This use of Se by microorganisms decreases the availability of this 
trace element for the expression of host selenoproteins. As a result, microbiota increases 
the requirement of the host for Se. However, because of unavailability of the genomes for 
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the majority of microorganisms that respond to Se status, it is not currently possible to 
directly link sensitivity to dietary Se and occurrence of specific Se utilization pathways. 
Bacterial colonization decreases total Se status of the host. Se is an essential 
trace element required for synthesis and functions of 24 selenoproteins in mice. GPx1 and 
TR1 are among the best studied mammalian selenoproteins. TR1 is an essential 
selenoprotein that controls the redox state of thioredoxin. Thus, the thioredoxin system 
(which is the main redox regulatory system) is dependent on dietary Se. GPx1 is the most 
abundant mammalian selenoprotein that catalyzes glutathione-dependent reduction of 
hydroperoxides. It is expressed at particularly high levels in liver and kidney. MsrB1 is 
another important oxidoreductase, which repairs oxidatively damaged proteins by reducing 
methionine sulfoxide residues to methionines. Various selenoproteins are differentially 
regulated by dietary Se in mice. Some selenoproteins, such as GPx1 and MsrB1, are 
sensitive to Se status, whereas several other selenoproteins, including TR1, are less 
susceptible to changes in dietary Se. Thus, mice and other mammals have a priority for Se 
supply that is selenoprotein- and tissue-specific. Under conditions of Se deficiency, GF 
mice were shown to possess higher GPx and TR activities in liver and intestine [129]. 
They also had higher expression of GPx1 and its mRNA in the liver and colon. In addition, 
plasma, liver, and cecum of these mice contained higher Se concentration compared to CV 
animals [129]. In our study, which compared GF mice with their CV controls, we also 
found GF mice to have elevated selenoprotein status, including higher GPx1 and MsrB1 
activities and expression in liver and kidney. On the other hand, Se levels were similar in 
GF and CV mice subjected to the same Se diets. This observation might be explained by 
the fact, that in a previous study [129], GF and CV mice were subjected to the diets for 5 
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wk, whereas in our work, we conventionalized the GF mice with the intestinal flora 
prepared from C57BL/6J mice. Perhaps, at different Se levels in the diet, somewhat 
different populations of microorganisms colonize the gut. In contrast to GPx1 and MsrB1 
status in GF and CV mice, we observed a trend toward an increased level of SelP in CV 
mice. A previous study investigated gene expression in colonic epithelial cells, derived 
from germfree and bacteria-reconstituted mice [132]. SelP gene expression was found to 
be down-regulated under these conditions. Moreover, SelP was only detected in the GF 
mice. Since SelP is a transport form of Se, its expression contributes to the Se status of the 
whole organism. This protein is regulated by the glucocorticoid receptor [133] and by 
cytokines during inflammation. Its expression is decreased during certain pathologies 
linked to chronic inflammation, such as liver cirrhosis and Crohn’s disease [38]. In 
addition, it is induced by IL-10, an anti-inflammatory cytokine [133], but suppressed by 
IFN-γ, TNF-α, IL-1, and TGF-β [134-136], which promote inflammation. The majority of 
plasma SelP comes from the liver. Its increase in CV mice might be explained by the 
indirect effect of cytokines on the expression of liver SelP or its increased use in organs of 
GF mice that are dependent on this protein for supplies of Se. 
Microbiota and the host Se status. Disruption of integrity of the intestinal 
microbiota may lead to diseases, such as inflammatory bowel disease and cancer. Se 
supplementation may be beneficial in the prevention of colon cancer and certain other 
cancer types. Our data suggest that the sensitivity of the microbiota to dietary Se may be 
relevant to the regulation of the host Se status. Our diets were chosen to mimic the dietary 
Se intake in the human population. For example, the 0.1-ppm Se diet approximately 
corresponds to the human recommended dietary allowance for adults, whereas 0.4 ppm Se 
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[94] may correspond to the diet supplemented with 200 µg Se/d, which is the dose most 
often used in human clinical trials involving Se. Thus, the effects observed with these diets 
in mice may be relevant to the effects of the human microbiota in setting the status of trace 
elements. In our experiments, the CV mice had higher requirements for Se compared to the 
GF mice, likely due to sequestration of Se by gut microorganisms, which compete for Se 
with the host. These data may also be relevant for understanding the mechanisms of Se 
mediated protection against malignant transformation of the colon epithelium, but further 
studies are required to test this idea. 
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Figure 2. Mouse models for examining the interrelationships between dietary 
Se, gut microbiota, and host Se status. A) Schematic illustration of selenoprotein 
expression in mice subjected to Se-deficient (0 ppm Se), Se-sufficient (0.1 ppm Se), and 
Se-enriched (0.4 ppm Se) diets. B, C) SelP expression was analyzed by Western blotting 
(WB) in plasma of conventional (B) and GF and CV (C) mice fed the indicated Se diets for 
8 wk (B) or 6 wk (C; top panels); gels stained with Coomassie blue served as loading 
controls (bottom panels); 2 mice/group were analyzed. 
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Figure 3. Effect of dietary Se on gut microbiota. A) Rarefaction analysis was 
performed on pyrosequencing data from conventional and GF conventionalized animals. 
Sequences were pooled from animals of a similar feeding level and aligned using the 
complete linkage clustering at 97% cutoff available on the RDP pipeline, and clusters were 
subjected to rarefaction analysis. B) Box and whisker plots depict relative abundance of 
selected phylotypes showing statistically significant effects of dietary selenium (P < 0.05). 
The taxonomic relationship of each phylotype is indicated above the relevant graph. Left 
panels: phylotypes from conventional animals (orange boxes). Right panels: phylotypes 
from GF conventionalized animals (light blue boxes). Vertical bars indicate range of 
proportions for each treatment group; boxes indicate upper and lower bounds of the 95% 
confidence intervals. 
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Figure 4. Selenoprotein expression in GF and CV mice. Expression (A) and 
specific GPx1 and MsrB1 activities (B) in livers and kidneys are shown; 3 mice/group 
were analyzed. A) Expression of GPx1 and MsrB1 was analyzed by Western blots in livers 
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(top panels) and kidneys (bottom panels) of CV and GF mice fed 0-, 0.1-, and 0.4-ppm Se 
diets. B) GPx and MsrB activities in liver and kidney lysates of GF and CV mice fed 0-, 
0.1-, and 0.4-ppm Se diets. Solid bars, CV mice; open bars, GF mice. *P > 0.05; Student’s 
t test. 
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Figure 5. Regulation of SelP expression by dietary Se in CV and GF mice. A) 
SelP levels in plasma of CV and GF mice fed 0-, 0.1-, and 0.4-ppm Se diets, as analyzed 
by Western blots. B) Liver SelP mRNA expression analyzed by quantitative PCR. SelP 
mRNA expression in CV mice fed the 0-ppm Se diet was set to 1, and mRNA levels in 
other groups were calculated relative to this basal level. Significance was analyzed with 
Student’s t test. C) Se levels in plasma in CV and GF mice fed 0-, 0.1-, and 0.4-ppm Se 
diets analyzed by ICP-MS. Values are expressed as means +/- sd. 
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Figure 6. Trace elements in CV and GF mice maintained on Se diets. Trace 
elements were analyzed with ICP-MS in tissues from CV and GF mice fed 0-, 0.1-, and 
0.4-ppm Se diets, as described in Materials and Methods. Values are means +/- sd. Organs 
in which trace elements were analyzed are indicated at the bottom of each panel. 
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CHAPTER 3 
 
15 kDa selenoprotein (Sep15) knockout mice: roles of Sep15 in redox 
homeostasis and cataract development 
 
Note: The results described in this chapter have been submitted for publication in 
the Journal of Biological Chemistry: 
Kasaikina M. V., Fomenko D. E., , Labunskyy V. M., Lachke S. A., Qiu W, Moncaster . 
A., Zhang J., Wojnarowicz M. W., Kumar S. N, Malinouski M. M, Schweizer U., Tsuji P. 
A., Carlson B. A., Maas R. L., Lou M. F., Goldstein L. E., Hatfield D. L. and Gladyshev 
V. N. (2011) “15 kDa selenoprotein (Sep15) knockout mice: roles of Sep15 in redox 
homeostasis and cataract development” 
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3.1 Abstract 
 
Sep15 is a thioredoxin-like, ER-resident protein involved in the quality control of 
glycoprotein folding through its interaction with UGT. Expression of Sep15 is regulated by 
dietary selenium and the unfolded protein response, but its specific function is not known. 
In the current study, we developed and characterized Sep15 KO mice by targeted removal 
of exon 2 of the Sep15 gene coding for the cysteine-rich UGT-binding domain. These KO 
mice synthesized a mutant mRNA, but the shortened protein product could be detected 
neither in tissues nor in Sep15 KO embryonic fibroblasts. Sep15 KO mice were viable and 
fertile, showed normal brain morphology and did not activate ER stress pathways. 
However, parameters of oxidative stress were elevated in the livers of these mice. We 
found that Sep15 mRNA was enriched during lens development. Further phenotypic 
characterization of Sep15 KO mice revealed a prominent nuclear cataract that developed at 
an early age. These cataracts did not appear to be associated with severe oxidative stress or 
glucose dysregulation. We suggest that the cataracts resulted from improper folding status 
of lens proteins caused by Sep15 deficiency. 
3.2 Introduction 
Sep15 was identified in mammals 13 years ago as a protein of unknown function 
[137]. The NMR structure of the Drosophila melanogaster Sep15 revealed a thioredoxin-
like fold within its oxidoreductase domain, with Sec located in the predicted catalytic 
position [20]. Previous studies showed that Sep15 resides in the endoplasmic reticulum 
(ER) and interacts with UDP-glucose:glycoprotein glucosyltransferase (UGT) [138]. The 
latter protein is a part of the calnexin-calreticulin glycoprotein folding cycle and is known 
to be responsible for targeting unfolded glycoproteins for calcium-dependent transient 
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glucosylation. Sep15 contains the ER targeting peptide, but lacks an ER retention signal; 
the tight binding to UGT allows retention of Sep15 in the ER. These findings suggested 
that Sep15 may assist UGT function and control folding or secretion of certain 
glycoproteins.  
Recently, Sep15 was found to be regulated by ER stress. Compounds causing mild 
ER stress, such as tunicamycin and brefeldin A, up-regulated Sep15 expression. At the 
same time, more robust ER stress agents, such as dithiothreitol (DTT), induced rapid 
proteasomal degradation of Sep15 [22]. Presumably, disruption of Sep15-UGT interaction 
due to reduction of disulfide bonds in the Sep15 UGT-binding domain displaced Sep15 
from the ER. Expression of Sep15 is higher in tissues with secretory functions, such as 
liver, kidney, prostate and thyroid [139]. Comparison of expression of Sep15 and other 
components of the protein folding quality control machinery revealed similar expression 
patterns in mouse brain, including enriched levels in hippocampus and cerebellum. This 
observation further pointed to the role of Sep15 in glycoprotein folding [22]. 
Several studies suggested a role of Sep15 in cancer prevention. First, the human 
Sep15 gene is located on chromosome 1p31, in the locus often deleted or mutated in 
human cancers. In addition, Sep15 has two polymorphic sites which differentially regulate 
expression of this protein in response to selenium supplementation [140]. Moreover, levels 
of Sep15 were decreased in prostate cancer cell lines and in hepatocarcinoma compared to 
non-transformed cells and tissues. Sep15 expression is also lowered in malignant lung, 
breast, prostate and liver [141]. These observations suggest a role of Sep15 in tumor 
suppression, possibly through regulation of folding and/or secretion of cancer-related 
glycoprotein substrates; however, the specific function of Sep15 in this process is not 
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understood. At the same time, recent research demonstrated an opposite role for Sep15 in 
the promotion of growth of colon cancer cells [142, 143]. Stable knockdown of Sep15 
significantly reduced growth of CT26 cells in culture and prevented formation of colonies 
on the soft agar. Mice, injected with the Sep15-deficient cells developed fewer tumors and 
did not form pulmonary metastases as did mice injected with control cells. However, 
Sep15 deficiency had no effect on the growth of lung cells.  
In the present study, we describe Sep15 KO mice, lacking exon 2 of the gene. 
Although the mutant mRNA was detected, the shortened dysfunctional Sep15 form was 
not present in these mice. Analyses of Sep15 KO mice did not reveal any signs of ER 
stress and any gross abnormalities. However, livers of Sep15 KO mice showed increased 
levels of malondialdehyde and protein carbonyls, indicative of mild oxidative stress. 
During the course of further analyses, we found that Sep15 mRNA was enriched in the 
developing ocular lens. Consistent with this observation, deficiency in the protein due to 
Sep15 KO resulted in the development of cataract. This study highlights the roles of Sep15 
in redox homeostasis and glycoprotein folding and indicates its function in the 
maintenance of lens transparency. 
3.3 Experimental Procedures 
Development of Sep15 KO mice. The Sep15 KO construct was prepared as 
follows. A 4,202 bp fragment of Intron 1 was amplified from 129/Sv mouse genomic DNA 
by nested PCR with the following primers: Round 1 5’-
CCAGTTAACTTCTACGGGTCTGTTACAAGTGGT-3’ and 5’-
GTCCAGGCTGGCCCTGAACTAGCTCTGTGC-3’; and Round 2 5’-
GTGGTCTCGAGTGGAAGCATCATTGACAGTTGATGGTACTGAAGTG-3’ and 5’-
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CTGTGCTCGAGACGACCTCACCCTGATTCTCCTGTCCAGTTCAGG-3’. The 
amplified fragment was cloned into the XhoI site of the pPNT vector. A second fragment 
of 4,246 bp of Intron 2 was amplified from 129/Sv mouse genomic DNA by nested PCR 
with the following primers: Round 1 5’-
GCATACCAGGATTCATTCCACTGAGGCTGTCC-3’ and 5’-
ACCCATCTTTATGGACGGTGTCACATGTC-3’; and Round 2 5’-
AGGACCGGATCCCAGGATCACCATTGCCCTAGGCTTCCTGG-3’ and 5’-
CCTGTGGATCCTGACTCTGCTGGCTGTGGTGGTTGTAGAGAAGC-3’. The 
amplified fragment was cloned into the BamHI site of pPNT vector. Correct insert 
orientation of fragments was confirmed by restriction analysis. The construct was digested 
with NotI, DNA fragments were separated by agarose gel electrophoresis and the targeting 
DNA was purified from the gel. 129/Sv embryonic stem cells were transfected with the 
targeting construct and recombinants were selected by growing stem cells in a neomycin-
containing medium. Clones with successful construct recombination were identified by 
nested PCR with the following primer pairs for the neo-cassette and genomic DNA that 
was not part of the targeting construct: Fragment 1, Round 1 5’-
GGGAAGACAGTACCTTGTCATGTAAGTGG-3’ and 5’-
GCTGCTAAAGCGCATGCTCCAGACTGCCTTGG-3’; Fragment 1, Round 2 5’-
CCAGTTAACTTCTACGGGTCTGTTACAAGTGG-3’, 5’-
CCTACCCGGTAGAATTGACCTGCAGG-3’; Fragment 2, Round 1 5’-
GAACGAGATCAGCAGCCTCTGTTCCAC-3’ and 5’-
ACCCATCTTTATGGACGGTGTCACATGTC-3’. Fragment 2, Round 2 5’-
GTTCTAATTCCATCAGAAGCTGACTCTAGA-3’ and 5’-
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CAGTCATGTTGCGCTGCCTTCCTGCCT-3’. Cells with proper construct integration 
were microinjected into C57Bl/6 blastocysts. The resulting chimeric mice were then mated 
with C57Bl/6 mice. Germline transmission was confirmed by nested PCR as described 
above. The KO allele was transferred to the C57Bl/6 background through five rounds of 
crossbreeding with C57Bl/6 mice, and homozygous Sep15 KO animals were then 
generated by crossbreeding of Sep15 KO heterozygous mice. The KO phenotype was 
confirmed by southern blotting, 75Se metabolic labeling and immunoblot analyses as 
described in the Results section. For the RT-PCR experiments, total liver RNA was 
isolated by TRIzol extraction according to the manufacturer’s protocol (Invitrogen). 
Genomic DNA was removed using a DNA removal kit (Ambion). RNA was quantified 
with a spectrophotometer, and 5 µg were transcribed with 50 ng of random primer and 200 
U of SuperScript III reverse Transcriptase (Invitrogen). 1 µL of the resulting cDNA was 
used for analysis with primers specific for various regions of the mouse Sep15 gene.  
Isolation of mouse embryonic fibroblasts (MEFs) and metabolic labeling with 
75Se. Embryos generated from wild type (WT) and Sep15 KO mice were dissected out at 
the 13.5 embryonic day and separated from maternal tissues. The embryos were treated 
with 0.05% trypsin at 4 °C for 30 min and incubated at 37 °C for 1 h. Embryonic cells 
were cultured in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 20% 
fetal bovine serum, 2 mM glutamine, 50 µM β-mercaptoethanol and 100 units/ml 
penicillin/streptomycin. After 4 weeks, an aliquot of cells was frozen, and another aliquot 
was used for further experiments. For the analysis of Sep15 expression, WT and Sep15 KO 
MEFs were grown in DMEM supplemented with freshly neutralized 75Se selenious acid 
(specific activity 1000 Ci/mmol, final concentration in the medium 1 nM) for 24 h. Sep15 
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was immunoprecipitated using a Protein G immunoprecipitation kit (Sigma) and 5 µl of 
Sep15-specific antibodies. Selenoproteins were visualized by SDS-PAGE followed by 
autoradiography using a PhosphorImager.  
Cloning and in vitro expression of Sep15 and Sep15∆2 forms. To analyze for the 
possibility of expression of the Sep15 form lacking the Cys-rich UGT-binding domain 
encoded by exon 2 (Sep15∆2), Sep15∆2 nucleotide sequence was amplified from Sep15 KO 
cDNA (prepared from total liver RNA) with primers 5’-
ATCACTCGAGATGGCGGCAGGGCAGG-3’ and 5’-
TGACTCTAGATTAATGATGATGATGATGATGTATGCGTTCCAACTTCTCG-3’ 
containing XhoI and XbaI restriction sites, and subcloned into pCI-neo using the 
corresponding restriction enzymes. The SECIS element was separately amplified with 5’-
TGACTCTAGATTAGTAGTTTTTATACTAATC-3’ and 5’-
ATGACGATCTGCGGCCGCTTTTTTTTAAAATCAAACATATTTGAAAG-3’ primers 
and cloned into the resulting vector at Xba1 and Not1 sites. For localization experiments, 
full-length Sep15 and Sep15∆2 sequences were cloned into pEGFPN1 vector with primers 
5’-ATCAGCTAGCATGGCGGCAGGGCAGG-3’ and 5’-
ACTTACAATATTACCGGTATTATGCGTTCCAACTTCTCG-3’ containing NheI and 
AgeI restriction sites. All constructs were verified by sequencing. Sec was substituted with 
Cys by site directed mutagenesis with primers 5’-
CTTGAAGTCTGCGGATGTAAATTGGGGAGGTTCC-3’ and 5’-
GGAACCTCCCCAATTTACATCCGCAGACTTCAAG-3’ (the introduced mutations are 
underlined). 
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Cell culture studies. Human HEK 293, mouse NIH 3T3 cells, and MEFs were 
cultured in DMEM medium supplemented with 10% FBS, 100 units/mL penicillin, and 
100 units/mL streptomycin. Transfections were carried out using Lipofectamine 
(Invitrogen) according to the manufacturer’s instructions. To analyze expression of Sep15 
and Sep15∆2, HEK 293 cells were transfected with pCI-neo vector coding for full-length 
Sep15 and Sep15∆2 forms, and, 18 h after transfection, medium was replaced with that 
containing freshly neutralized 75Se selenious acid (specific activity 1000 Ci/mmol, final 
concentration in the medium 1 nM). Cells were metabolically labeled for 24 h, and 
expression of selenoproteins was analyzed by SDS-PAGE followed by autoradiography.  
To further analyze expression of full-length and Sep15∆2 forms, NIH 3T3 cells 
were grown in 6-well plates and transfected with the corresponding EGFP fusion 
constructs or with an empty vector. Twenty-four hours after transfection, the original 
medium was replaced with serum-free medium, and after an additional 24 h, cells and 
media were collected. Cell lysates were prepared using CellLytic buffer (Sigma) according 
to the manufacturer’s instructions. The conditioned media were concentrated to 40 µl using 
Centricon concentrators (Millipore). Cell extracts and concentrated media samples were 
analyzed by Western blotting using GFP-specific antibodies (Sigma).  
To further characterize expression of full-length and Sep15∆2 forms, NIH 3T3 cells 
were grown on cover slips, transfected with the corresponding constructs in pEGFPN1 
expression vector, and 24 h after transfection, treated with 1 µM ER-Tracker Blue-White 
DPX dye (Invitrogen) for 20 min. Then, cells were washed with PBS, fixed in 4% 
formaldehyde in PBS and mounted with mount media. Images were collected using a 
BioRad MRC1024ES laser scanning microscope. 
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Metabolic labeling of WT and Sep15 KO mice. WT, heterozygous and 
homozygous Sep15 KO mice were injected each with 40 µCi of freshly neutralized 75Se 
selenious acid and maintained on a 12 h light/dark cycle and a regular diet. After 48 h, 
mice were sacrificed and extracts prepared from various tissues in ice-cold PBS, pH 7.6, 
supplemented with complete protease inhibitor mixture (Roche Applied Science). Extracts 
from the indicated tissues were subjected to SDS-PAGE, and proteins were transferred 
onto polyvinylidene difluoride membranes and analyzed with a PhosphorImager. 
Tissue and blood preparation. Blood was obtained from sacrificed Sep15 KO and 
control mice from the heart vein. Brain and prostate tissues were immediately fixed in 10% 
neutral buffered formalin and washed with PBS. PBS-washed tissues were embedded in 
paraffin and cut on a standard microtome to 5 µm sections. The sections were 
deparaffinized in xylene and stained with hematoxylin (Invitrogen) and eosin (Sigma) to 
reveal the fine tissue structure. Images were taken using a light Olympus AX70 
microscope. For prostate-specific antigen (PSA) analysis, erythrocytes were removed by 
centrifugation, and 30 µg of serum proteins were analyzed by Western blotting with PSA-
specific antibodies (Dako). Brains were stained with the indicated antibodies at dilutions of 
1:1,000–1:5,000 at 4 °C overnight. 
Analyses of oxidative stress parameters. Protein extracts from liver, kidney, heart, 
testis, and brain were prepared in PBS containing a complete protease inhibitor mixture. 
Malondialdehyde was measured using the Oxiselect TBARS assay kit (Cell Biolabs) 
according to the manufacturer's instructions. Protein carbonyl content was assayed using 
2,4-dinitrophenyl hydrazine and (molar extinction coefficient of 22 mm-1 cm-1). Total and 
protein thiol contents were measured using 5,5′-dithiobis (2-nitrobenzoic acid). 
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Analysis of SelP secretion in hepatocytes. Hepatocytes of WT and Sep15 KO 
mice were obtained according to the previously published procedures [144, 145]. Briefly, 
livers from 3-month old mice were perfused with Ca2+ and SO42- free buffer (6 mM 
glucose, 115 mM NaCl, 25 mM NaHCO3, 6 mM KCl, 1 mM MgCl2x6H2O, 1mM 
NaH2PO4). After liver was cleared from the blood, collagenase (700 units/ml, Sigma) was 
added at the concentration of 0.1 mg/ml. Tissues were removed and dissociated by gentle 
rubbing in perfusion buffer. The suspension was then filtered through a 70 µm cell strainer 
by gravity flow. Then, hepatocytes were washed 3 times in Williams E medium (Sigma) 
supplemented with 2 mM L-glutamine (Invitrogen) seeded on collagen-coated 5 cm plates. 
Fourty eight hours later, the medium was replaced with 3 ml of serum-free medium 
containing freshly neutralized 75Se selenious acid and supplemented with DMSO or ER 
stress-inducing agents 1 mM DTT, 10 µg/ml brefeldin A, 5 µg/ml tunicamycin, or 20 µM 
monensin. Cells and media were collected 24 h later, and media samples were concentrated 
as described above for NIH 3T3 cells. Cell lysates and concentrated media were analyzed 
by SDS-PAGE followed by autoradiography.  
Tunicamycin injection. WT and Sep15 KO mice were given a single 1 µg/g body 
weight intraperitoneal injection of a 0.05 mg/ml suspension of tunicamycin in 150 mM 
dextrose as described [146]. These mice were euthanized 72 h after injection, and their 
livers were removed. Protein lysates were resolved by SDS-PAGE and analyzed by 
Western blotting using antibodies specific for Sep15, BiP and β-actin. 
Phenotypic screening of cataracts. Phenotypic screening was performed via slit 
lamp examination as described [147]. Mouse pupils were dilated by 1% atropine, and 15 
min later lenses were examined with a slit lamp. Observed opacities were quantified using 
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Lens Opacities Classification System, version II (LOCS II) [147-149]. For ex vivo 
phenotyping, eyes were dissected for lens phenotyping by ex vivo dark field 
photomicroscopy as previously described [150, 151]. For measurement of glucose levels, 
mice were fasted for 8 h. Glucose was measured in blood from the tail vein using Elite 
system (Bayer) glucometer as described by the manufacturer. The data were analyzed with 
ANOVA (p<0.05 for limit). 
3.4 Results 
Generation of the Sep15 KO mice. Sep15 KO mice were generated by 
homologous recombination. The KO construct was designed to exchange exon 2 with the 
selection marker followed by a transcription termination signal (Fig 7A, B). Genotypes of 
mice were confirmed by PCR analysis. However, subsequent RT-PCR analysis showed a 
signal of Sep15 mRNA in Sep15 KO tissues. To determine the organization of this mRNA, 
we used primer pairs for various parts of the Sep15 mRNA (Fig 7C). Amplification with 
primers specific for the first and third exons gave fragments of different sizes in WT and 
Sep15 KO mice, while the use of primers downstream of exon 3 showed fragments of 
similar size. Further sequencing of the fragment amplified with primers specific for exons 
1 and 5 revealed that the truncated Sep15 KO mRNA lacked exon 2. However, since the 
reading frame was preserved and the shortened mRNA form had both an in-frame UGA 
codon and SECIS element in the 3’-UTR, the possibility that the mutant mRNA supported 
Sec insertion and therefore selenoprotein synthesis had to be considered. To test for 
possible expression of the shortened protein product in Sep15 KO mice, we prepared 
MEFs from WT and Sep15 KO mice and subjected them to metabolic labeling with 75Se 
(Fig 7D). Selenoprotein patterns were similar in WT and Sep15 KO MEFs, with the 
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exception of a 14 kDa band that was missing in Sep15 KO MEFs. This band corresponded 
to the migration property of Sep15 following removal of the N-terminal signal peptide. To 
verify that the 14 kDa band was Sep15, we carried out immunoprecipitation with Sep15-
specific antibodies. This analysis precipitated a 14 kDa protein in WT MEFs, but not in 
Sep15 KO MEFs (Fig 7D). In addition, we did not detect any selenoprotein bands 
migrating lower than 14 kDa in either WT or Sep15 KO samples subjected to 
immunoprecipitation. These data suggested that Sep15 KO mice express neither Sep15 nor 
its shortened form lacking sequences encoded by exon 2.   
Characterization of the truncated Sep15∆2 form. Since Sep15 KO mice 
synthesized a shortened mRNA form, we further examined the possibility that it could 
code for a protein fragment. The predicted size of Sep15 selenoprotein lacking the region 
encoded by exon 2 (further designated Sep15∆2) is 107 amino acids (11.6 kDa) (Fig 8A, 
B). Transfection of the Sep15∆2 construct into HEK 293 cells did not reveal a band of the 
expected size when cells were labeled with 75Se. We also tested the possibility that 
Sep15∆2 was secreted by cells because it lacked the domain that retained the protein in the 
ER due to interaction with UGT. To exclude this possibility, we prepared constructs for 
Cys mutants (i.e., Cys replacing Sec) of Sep15∆2 and Sep15 fused with GFP. HEK 293 
cells transfected with these constructs showed Sep15∆2-GFP and Sep15-GFP bands, and 
these protein forms were absent in the medium (Fig 8D). We also transfected NIH 3T3 
cells with the same constructs and examined localization of Sep15 protein forms (Fig 8E). 
Full-length Sep15-GFP colocalized with the ER tracker, while Sep15∆2-GFP showed a 
different localization pattern, wherein the protein seemed to be in granules (it did not 
correspond to mitochondria or lysosomes). Thus, Sep15∆2 was not expressed in transfected 
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mammalian cells, based on Western blot data, extremely sensitive 75Se labeling of cell 
lysates, and immunoprecipitation of Sep15 from 75Se-labeled cells. When Sep15∆2 was 
fused to a large globular protein (i.e., GFP) and, in addition, had its Sec replaced with Cys 
(Sec insertion is very slow and replacing this residue with Cys is a method to dramatically 
increase protein expression), the protein could be expressed, but it changed localization. 
We conclude from the above observations that Sep15 KO cells lack functional Sep15. 
Absence of Sep15 does not affect expression of other selenoproteins. 
Selenoprotein expression depends on availability of dietary Se [128]. In addition, removal 
of one selenoprotein may affect expression of other selenoproteins, e.g., due to increased 
availability of Sec-tRNA or by influencing redox homeostasis. To examine this possibility, 
WT and heterozygous and homozygous Sep15 KO mice were metabolically labeled with 
75Se (Fig 9). However, expression of other selenoproteins was unchanged.  
Oxidative stress in Sep15 KO mice. We examined parameters of oxidative stress 
in livers of WT and Sep15 KO mice. Sep15 KO livers showed increased levels of 
malondialdehyde (p <0.0001) and protein carbonyls (p <0.0001), while amounts of total 
thiols and protein thiols were found to be decreased compared to controls (p<0.05) (Fig 
10). The data show increased lipid and protein oxidation, and suggest mild oxidative stress 
in Sep15 KO livers. 
Analysis of Sep15 KO mice for prostate and brain pathologies. Sep15 is 
expressed at elevated levels in prostate, liver, kidney, testis, and brain. At the same time, 
Sep15 expression is decreased in malignant prostate cell lines and in hepatocarcinoma 
[22]. We examined Sep15 KO mice for phenotypes associated with prostate and brain. 
Prostate was examined in 1.5 year-old males (n=13) (Fig 11A. No signs of neoplasia were 
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observed. PSA is a plasma protein, whose expression is increased during prostate 
pathologies, such as inflammation and malignant transformation. No differences in PSA 
levels were observed in serum samples of WT and Sep15 KO mice (Fig 11B).  
Selenoprotein deficiency is also known to be associated with neuronal pathology 
[40]. For example, mice lacking SelP show seizures and ataxia and die before weaning 
when fed a Se-deficient diet [152]. Comparative analysis of gene expression data in the 
Allen Brain Atlas revealed expression of all selenoproteins and selenocysteine 
incorporative machinery in the brain, including high expression of Sep15 [153]. In 
addition, disruption of neuronal expression of selenoproteins led to neurological symptoms 
and neurodegeneration [114, 154]. Similar symptoms were observed in glutathione 
peroxidase 4 (GPx4) KO mice [155] and in TrsptAE/AE mice expressing hypomorphic 
tRNA(Ser)Sec [114]. Sep15 expression is high in Ammon’s horn and dentate gyrus of 
hippocampus and in Purkinje cells of the cerebellar cortex [153]. We analyzed brains of 
Sep15 KO mice (Fig 11). The hippocampal area of Sep15 KO mice showed no signs of 
astrogliosis, and its levels of glial fibrillary acidic protein and parvalbumin were similar to 
those in WT mice. Thus, Sep15 deficiency did not lead to the loss of parvalbumin positive 
interneurons observed in mouse models with general deficiency in selenoprotein 
expression. Analysis of cerebellum morphology of Sep15 KO mice also did not reveal 
abnormalities. Thus, Sep15 deficiency does not lead to spontaneous neurodegeneration, 
consistent with an apparent lack of behavioral phenotypes.  
Sep15 deficiency does not influence SelP secretion. As a UGT-binding partner, 
Sep15 may be involved in protein folding and secretion. Sep15 is also regulated by the 
unfolded protein response (UPR). SelP is a major plasma selenoprotein, synthesized in the 
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liver and transporting Se to other organs. SelP maturation, intracellular transport and 
secretion occur through the common ER-Golgi pathway in the liver [156]. We examined 
the possibility that Sep15 KO affects SelP secretion. Hepatocytes from WT and Sep15 KO 
mice were isolated and metabolically labeled with 75Se. The cells were also treated with 
compounds that compromize function of the ER-Golgi pathway (Fig 12). This treatment 
did not affect the viability of cells (data not shown). Treatment of hepatocytes with 
brefeldin A is known to abrogate SelP secretion, which is what we observed in both WT 
and Sep15 KO hepatocytes, while treatment with tunicamycin and monensin caused 
accumulation of intracellular non-glycosylated or partially glycosylated SelP forms. 
However, this difference disappeared after the treatment with tunicamycin, an inhibitor of 
GlcNAc phosphotransferase. As expected, treatment with this compound induced 
expression of BiP in Sep15 KO hepatocytes. 
Sep15 deficiency does not lead to activation of the UPR. To further assess the 
function of Sep15, WT and Sep15 KO mice were injected intraperitoneally with 1 µg/g 
body weight tunicamycin or vehicle and sacrificed 72 h after injection. This treatment 
induced both BiP and Sep15 expression in WT mice (Fig 13), consistent with previous data 
in cell culture [22]. BiP was elevated similarly in WT and Sep15 KO mice, so the absence 
of Sep15 did not augment the UPR.  
Sep15 mRNA expression is progressively lens-enriched during mouse 
development. Because our data suggested that Sep15 may play a role in the quality control 
of protein folding, we hypothesized that deficiency in this protein may lead to protein 
misfolding or aggregation. A prominent human disease associated with altered protein 
folding is cataract, with opacities caused by aggregation of lens structural proteins, such as 
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α-crystallins. It has been proposed that genes that are expressed in a lens-enriched manner 
in the developing mouse lens may have a functional role in the development and 
maintenance of lens transparency and therefore may represent candidate genes for cataract 
[157, 158]. In this approach, lens enrichment of a candidate gene is scored against its 
expression in whole embryonic tissues at various stages in development (Lachke and 
Maas, unpublished). This approach has been successful in identifying previously described 
cataract loci. Therefore, we investigated if Sep15 mRNA was enriched in the lens during 
stages of lens invagination (E10.5) through primary fiber cell differentiation (E12.5). We 
found expression of Sep15 mRNA to get progressively enriched at E12.5 (Fig 14).  
Development of cataract in Sep15 KO mice. To directly assess cataract formation 
in Sep15 KO mice, we carried out slit lamp examination for cataract scoring, which 
revealed lens opacity in both male (n=10) and female (n= 7) Sep15 KO mice (Fig 15A). 
Observed opacities were quantified using Lens Opacities Classification System, version II. 
Nuclear changes were classified by scoring the degree of opalescence. In our experiment, 
clear lens was assigned a grade of 0 and the fully opaque lens a grade of 5. The opacity 
grade increased with age, based on the comparison of 1.5 and 6-month old females (n=12). 
Fundus camera examination was also conducted, and representative images are shown in 
Fig 15B. A group of Sep15 KO mice was examined by slit lamp followed with ex vivo 
phenotyping, including lens dissection followed by microscopy analyses. In this 
experiment, we used 2.5-month old males (n=3) and females (n=3) as well as 10 month old 
males (n=4) and females (n=3). Both lenses of each KO mouse showed nuclear opacity, 
which increased in size with age. Sep15 KO mice predominantly developed nuclear 
cataract. Representative images of the lenses dissected from 2 month and 10 month Sep15 
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KO and control mice are shown in Fig 15 C-H and. Although some of the 10 month old 
control mice developed age-related punctate opacity (Fig 15H), the cataract in Sep15 KO 
mice was more prominent and occurred in all mice. Moreover, all examined 2 month old 
Sep15 KO mice had cataract, whereas it was not observed in 2 month old controls. These 
data show that Sep15 KO mice develop nuclear cataract. 
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3.5 Discussion 
Sep15 is an ER-resident protein implicated in the calnexin-dependent quality 
control cycle. Our previous studies showed that Sep15 forms a 1:1 complex with UGT, a 
protein that recognizes improperly folded or partially unfolded glycoproteins and subjects 
them to the calnexin cycle. In addition to the Cys-rich UGT-binding domain, Sep15 has a 
thioredoxin-like domain containing a redox active CxU (Cys and Sec separated by another 
residue) motif, suggesting a thiol oxidoreductase function for this protein. Sep15 is also 
differentially regulated by ER stress. Mild stress, e.g., caused by tunicamycin or brefeldin 
A treatments, induces Sep15 expression, whereas acute stress, e.g., caused by treatments 
with disulfide-reducing DTT or thapsigargin, a compound that disrupts calcium flux from 
the ER, leads to a rapid proteasomal degradation of Sep15 [22]. However, the specific 
function of Sep15 in these processes is not known. Sep15 is expressed at elevated levels in 
secretory organs, such as prostate, liver, kidney, testes, and brain. At the same time, Sep15 
expression was shown to be decreased in prostate cancer cells and in hepatocarcinoma. It 
was also found that stable Sep15 knockdown makes cells more susceptible to oxidative 
stress.  
In the current study, we generated and characterized Sep15 KO mice, which were 
viable and fertile, and with no obvious phenotypes during development and growth. These 
mice were obtained by deleting exon 2 coding for the UGT-binding domain of Sep15. 
Although the mRNA for a shortened Sep15 form was synthesized, the corresponding 
protein could not be detected under any conditions tested. Moreover, even when this 
protein form was forced into expression in cell culture by fusion with GFP and 
replacement of Sec with Cys, it had an abnormal localization. Therefore, Sep15 KO mice 
lacked functional Sep15.      
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Initial characterization of Sep15 KO mice revealed no phenotypes with regard to 
expression of other selenoproteins, susceptibility to treatments that induce ER stress, or 
protein secretion. Strong interaction between Sep15 with UGT implied the role of Sep15 in 
the quality control of glycoprotein folding. Thus, we analyzed the effect of Sep15 
deficiency on secretion of plasma glycoprotein SelP. However, no differences were found 
between WT and Sep15 KO hepatocytes subjected or not subjected to ER stress. 
Apparently, SelP is not a target of Sep15. Previous experiments in cell culture also 
suggested the involvement of Sep15 in the UPR. Therefore, we examined the levels of BiP 
(a marker of UPR) in WT and Sep15 KO hepatocytes. Tunicamycin treatment led to a 
robust increase in BiP expression in Sep15 KO hepatocytes; however, this protein was 
induced to a similar level in WT and Sep15 KO mice.  
Although the observed phenotypes of Sep15 KO mice were mild, we reasoned that 
since Sep15 is elevated by the UPR, Sep15 deficiency might modulate development of 
certain ER stress associated diseases. One such disease is cataract formation resulting from 
improper protein folding and posttranslational modifications, leading to decreased lens 
transparency. It has been proposed that lens-enriched genes may represent promising 
targets associated with cataract formation. Recently, deficiency of a gene with a highly 
lens-enriched expression pattern was found to cause congenital cataracts in humans, mice 
and chicken [157, 158]. We found that Sep15 mRNA was progressively enriched in three 
critical stages of mouse lens development. In addition, transcripts for several proteins 
functionally linked to Sep15 were found to be enriched in the lens (e.g., UGT1, 
calreticulin) while others (e.g., UGT2, calnexin, ERp57, SelM) although not enriched are 
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expressed in the lens. This provides further support that the Sep15 function is important in 
the lens. 
Further analysis revealed that nearly every Sep15 KO mouse developed mild 
nuclear cataract, some as early as 1.5 months of age. One of the factors that may influence 
cataract formation is glucose imbalance. We analyzed glucose levels in fasted mice, but 
they were comparable to those in WT controls (Fig 16). Cataracts may also result from 
increased protein oxidation and aggregation. Indeed, we found that Sep15 KO mice 
showed increased levels of both lipid and protein oxidation. To further examine this 
possibility, we analyzed the ratio of reduced to oxidized glutathione and levels of thiols in 
lenses. However, these parameters were similar in Sep15 KO and WT lenses (Fig 16 B, C). 
Therefore, it remains to be determined if Sep15 KO induced cataracts are directly 
associated with general oxidative stress. Another explanation for cataract formation is the 
improper folding or disulfide status of Sep15 targets. For example, similar symptoms were 
previously described in mice lacking connexin 46 [159, 160] Connexins are a family of 
gap junction proteins, whose mutations are associated with cataract development in human 
subjects [161, 162]. In the case of Sep15 KO cataracts, further studies are needed to 
determine the precise function of Sep15 in protein folding, but interaction of this 
selenoprotein with the protein folding sensor is consistent with the role of protein 
misfolding in Sep15-dependent cataract development.  
Overall, this study shows that the absence of Sep15 does not affect viability and 
does not lead to obvious phenotypes in mice. To better understand Sep15 function and the 
role of this selenoprotein in glycoprotein folding, it would be important to identify the 
subset of Sep15 targets and examine their posttranslational modifications in WT and Sep15 
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KO mice. Cataract is the major cause of blindness in the world. Several types of cataracts 
are associated with excessive ER stress and the UPR [163, 164]; however, little is known 
about the link between defective protein secretion pathways and cataract formation. Future 
experiments in this direction may lead to a better understanding of the association between 
abnormal glycoprotein folding/modification and human disease. 
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Figure 7. Preparation of Sep15 KO mice. (A) Structure of the mouse Sep15 gene. 
(B) Structure of the KO allele. Coding regions are shown in orange and DNA flanking 
regions used for homologous recombination are shown in green. The second exon was 
replaced with the Neo gene containing a transcription termination signal. (C) RT-PCR 
analysis of Sep15 mRNA in WT and Sep15 KO mice with primers for the indicated 
regions of Sep15. Aldolase gene was used as a control. (D) Analysis of Sep15 expression 
in MEFs derived from WT and Sep15 KO mice. Cells were labeled with 75Se followed by 
immunoprecipitation with antibodies specific for Sep15. Two lanes on the left show 
labeled MEFs. Immunoprecipitated (i.p.) and flow through (flow) fractions are shown for 
each MEF line in the right lanes. Arrow on the right indicates migration of Sep15.  
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Figure 8. Characterization of a shortened Sep15 form. (A) Amino acid sequence 
and predicted size of Sep15∆2. (B) Schematic representation of domain organization of 
Sep15 and its correspondence to gene structure. (C) Sep15 and Sep15∆2 were expressed in 
HEK 293 cells followed by labeling of cells with 75Se. Expression of proteins was 
compared to the selenoprotein expression profile in MEFs derived from WT and Sep15 KO 
mice. (D) Western blot analysis of Cys mutants of Sep15-EGFP and Sep15∆2-EGFP 
expressed in NIH 3T3 cells. Protein expression was analyzed in cell extracts and 
concentrated media. (E) Localization of Sep15 and Sep15∆2. Colocalization of Sep15 
forms (green) and the ER marker (blue) is shown.  
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Figure 9. Metabolic labeling of WT and Sep15 KO mice with 75Se. WT 
(Sep15+/+), and heterozygous (Sep15+/-) and homozygous (Sep15-/-) Sep15 KO mice were 
injected each with 40 µCi of 75Se. Selenoprotein expression was analyzed in indicated 
organs by SDS-PAGE followed by PhosphorImager.  
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Figure 10. Oxidative stress in Sep15 KO mice. Levels of malondialdehyde, 
protein carbonyls, total thiols and protein thiols in livers of WT (white bars) and Sep15 KO 
(black bars) mice are shown as mean +/- SD. (* p<0.001). 
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Figure 11. Analyis of prostate and brain pathologies in Sep15 KO mice. (A) 
H&E staining of prostate sections in WT and Sep15 KO mice. (B) Western blot analysis of 
PSA in serum of WT and Sep15 KO mice (upper panel). Coomassie Blue staining as a 
protein loading control (loading). (C) Analysis of brain sections: Nissl, GFAP and 
parvalbumin staining of the hippocampal area of WT and Sep15 KO mice. Also shown are 
immunohistochemistry of cerebral cortex area with GFAP antibodies and Nissl staining of 
cerebellum. 
 
  
 Figure 12. Sep15 deficiency does not affect SelP secretion.
isolated from WT and Sep15 KO mice 
PhosphorImager analysis of cellular extracts (left panel) and concentrated media (right 
panel). Membranes were further analyzed with BiP and 
(lower right panel) antibodies.
 
 
 Hepatocytes were 
and metabolically labeled with 75Se. 
β-actin (lower left panels) and SelP 
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Figure 13. Sep15 deficiency does not lead to activation of the UPR. WT and 
Sep15 KO mice were injected intraperitoneally with tunicamycin (Tun) (1 µg/g body 
weight) or vehicle. 72 h after injection, mice were euthanized, livers extracted and protein 
lysates from livers probed by immunoblot assays with polyclonal antibodies specific for 
Sep15 and BiP, or monoclonal β-actin antibody as a loading control. 
 
 
  
  Figure 14. Enrichment of Sep15 mRNA during lens development. 
mRNA expression was analyzed at the indicated stages of embryogenesis and compared to 
the whole body Sep15 mRNA expression (WB).
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Figure 15. Development of cataract in Sep15 KO mice. (A) Quantification of slit 
lamp examination of control and Sep15 KO mice. Opacity was quantified using the Lens 
Opacities Classification System, version II. The scale was from completely clear (grade 0) 
to fully opaque (grade 5) lens. L indicates left and R right. (B) Representative images of 
opacities in Sep15 KO mice using Fundus Camera. Six-month old WT and Sep15 KO 
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females were used. L indicates left and R right. (C-H) Representative cataracts in Sep15 
KO mice. Each panel shows lens from the same animal. Left images represent in vivo slit 
lamp examination, and the right images show dark field analyses of the same lens 
examined in vitro. (C, D) Representative lenses from 2-month-old Sep15 KO females. 
Nuclear opacity is shown with a red arrow. (E) 2-month-old WT female (control), which 
shows no nuclear opacity. (F, G) 10-month-old Sep15 KO females. Nuclear opacity is 
shown with red arrows. (H) 10-month-old WT female, which developed age-related 
punctate opacity. 
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Figure 16. Comparison of glucose levels and oxidative stress parameters in 
lenses of WT and Sep15 KO mice. (A) WT and Sep15 KO mice were fasted overnight 
and blood was analyzed for glucose levels (n=9 for WT and 12 for Sep15 KO mice). (B) 
Lenses were extracted from WT and Sep15 KO mice. Protein extracts were analyzed for 
(B) ratio of oxidized to reduced glutathione and (C) total thiol levels. In each group, n=3.  
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CHAPTER 4 
 
Reduced utilization of selenium by naked mole rats due to a specific defect in 
GPx1 expression 
 
 
Note: The results described in this chapter have been published. 
Kasaikina, M.V., Lobanov, A.V., Malinouski, M.Y., Lee, B.C., Seravalli, J., 
Fomenko, D.E., Turanov, A.A., Finney, L., Vogt, S., Park, T.J., Miller, R.A., Hatfield, 
D.L. & Gladyshev, V.N. 2011, "Reduced utilization of selenium by naked mole rats due to 
a specific defect in GPx1 expression", Journal of Biological Chemistry, in press. 
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4.1 Abstract 
Naked mole rat (MR) Heterocephalus glaber is a rodent model of delayed aging 
because of its unusually long lifespan (>28 years). It is also not known to develop cancer. 
In the current work, tissue imaging by X-ray fluorescence microscopy and direct analyses 
of trace elements revealed low levels of selenium in the MR liver and kidney, whereas MR 
and mouse brains had similar selenium levels. This effect was not explained by uniform 
selenium deficiency as methionine sulfoxide reductase activities were similar in mice and 
MR. However, glutathione peroxidase activity was an order of magnitude lower in MR 
liver and kidney than in mouse tissues. In addition, metabolic labeling of MR cells with 
75Se revealed a loss of the abundant GPx1 band, whereas other selenoproteins were 
preserved. To characterize the MR selenoproteome, we sequenced its liver transcriptome. 
Gene reconstruction revealed standard selenoprotein sequences except for GPx1, which 
had an early stop codon, and SelP, which had low selenocysteine content. When expressed 
in HEK 293 cells, MR GPx1 was present in low levels and its expression could be rescued 
neither by removing the early stop codon nor by replacing its SECIS element. In addition, 
GPx1 mRNA was present in lower levels in MR liver than in mouse liver. To determine if 
GPx1 deficiency could account for the reduced selenium content, we analyzed GPx1 
knockout mice and found reduced selenium levels in their livers and kidneys. Thus, MR is 
characterized by the reduced utilization of selenium due to a specific defect in GPx1 
expression. 
4.2 Introduction 
Naked mole rat (Heterocephalus glaber; MR) is a unique organism in the 
mammalian order rodentia. It is an attractive model to study aging due to an extraordinary 
lifespan (more than 28 years), which is unprecedented for rodents of similar body size. 
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Aging in MRs is characterized by very slow age-related declines that do not significantly 
affect breeding capacity, social behavior and daily activity [165-167]. MR evolved a 
unique eusocial lifestyle with strictly determined social roles and cooperative breeding 
within the colony. The anatomy of MR has several specific features, which probably 
evolved as an adaptation to living underground in oxygen limiting conditions, including 
underdevelopment of the visual system [168], skin insensitivity [169], and ability to 
tolerate low temperature [170] and low oxygen levels [171]. MRs are also characterized by 
a decreased metabolic rate, which is associated with reduced levels of thyroid hormones 
[167]. One of the most remarkable features of MR is that none of the autopsies of dead 
animals in several colonies revealed cancer incidence [165]. Moreover, primary fibroblasts 
derived from MR were sensitive to contact inhibition [172], resistant to experimentally 
induced tumorigenesis and unable to form xenograft tumors [173].  
MR poses a challenge to the theories that link aging, cancer and oxidative stress. 
Since MR lives in low oxygen conditions, it is expected to have low levels of oxidative 
stress. However, research showed that MR is characterized by significant oxidative 
damage. Compared to mice, MRs have lower GSH/GSSG ratio, higher rate of lipid 
peroxidation, high rate of DNA oxidative damage and higher protein carbonylation [174]. 
It was also demonstrated that MR proteins possess higher levels of protein thiols, increased 
protein stability, increased resistance to urea-induced denaturation and elevated 
proteasomal activity, while also showing lower levels of protein ubiquitination. Moreover, 
unlike the mouse proteome, the MR proteome did not show significant age-related 
susceptibility to oxidation and ubiquitination [175]. A separate study did not detect age-
related changes in the activities of antioxidant enzymes, including Mn superoxide 
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dismutase (SOD), Cu/Zn SOD, and catalase, and also observed low glutathione peroxidase 
(GPx) activity [176].  
Mammals have eight GPxs, including five selenoproteins. GPx1 is the first 
identified and one of the best studied selenoproteins [1]. This and other selenoprotein GPxs 
have selenocysteine (Sec) residues in their active sites. GPx1 is a cytosolic enzyme and the 
most abundant selenoprotein in mammals. Other GPxs show different cellular localizations 
and/or tissue and substrate specificities [11, 177]. GPx1 is not an essential enzyme, i.e., 
GPx1 knockout mice are viable and fertile. However, they are more susceptible to 
oxidative stress [58, 178] and viral myocardites [179]. Expression of GPx1 is decreased in 
prostate cancer and breast cancer cell lines [180], as well as in the mouse model of liver 
cancer [181]. A single nucleotide polymorphism that changes Pro to Leu at the codon 198 
of human GPx1 is associated with lung [182] and bladder [183] cancers. 
Currently, there is no information on the utilization of selenium (Se) by MR; 
however, this is an essential trace element in mammals and its supplementation may be 
beneficial in cancer chemoprevention [184]. Se functions mostly through incorporation 
into proteins in the form of Sec. Mice and humans have 24 and 25 selenoprotein genes, 
respectively [10]. However, nothing is known about the composition of the MR 
selenoproteome.  
In this study, we observed low levels of Se in MR tissues. This observation led to 
the finding that the reduced utilization of Se by this organism was due to a specific defect 
in GPx1 expression.  
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4.3 Experimental Procedures 
Animals. Animal experiments were approved by IACUC committees at University 
of Illinois at Chicago and University of Nebraska-Lincoln. To carry out ICP-MS analyses, 
western blotting, activity assays and other analyses, animals were sacrificed, their tissues 
frozen in liquid nitrogen and stored until use. To prepare extracts, tissues were 
homogenized in PBS supplemented with a protease inhibitor cocktail (Sigma). Cellular 
debris was removed by centrifugation at 13,000 rpm for 15 min at 4 °C, and protein 
concentrations were determined by the Bradford assay.  
Tissue samples for X-ray fluorescence microscopy (XFM). Tissues from 
C57BL/6 mice and MRs were extracted and prepared at the same time to match 
preparation conditions. Mice were fed standard rodent chow diet. MRs were fed either a 
sweet potato or carrot diet. Tissues from a 1 year old MR were compared with the 
corresponding samples of a 2 month old mouse to adjust for lifespan differences. All 
freshly extracted tissues were washed in PBS and placed in 4% neutral buffered 
formaldehyde in PBS for fixation. After 12 h, tissues were transferred to PBS, paraffin 
embedded, and cut using a standard microtome into 5 µm sections. Sections were mounted 
on silicon nitride windows (2 x 2 mm; 200 nm thickness, Silson, Blisworth, UK). Light 
microscopy images were taken using a Leica DMXR microscope (Leica Microsystems, 
Bannockburn, IL). 
XFM. Trace elements in mouse and MR tissue samples were imaged with XFM at 
the Advanced Photon Source (APS), Argonne National Laboratory (Argonne, IL). For 
each pixel, full X-ray fluorescence spectrum was recorded using a single-element silicon 
drift detector (Vortex EX, SII Nanotechnology, Northridge, CA). Dwell time varied from 
1.1 sec to 4 sec per pixel. For quantification, each set of experiments was followed by 
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recording X-ray fluorescence spectra of thin-film standards NBS-1832 and NBS-1833 
(National Bureau of Standards, MD). X-ray fluorescence spectra for each sample were 
fitted and quantified using data derived from standards. Image processing and analysis 
were performed using MAPS software [185]. Each X-ray fluorescence image represents 
2D distribution of the element.  
Activity assays. Total GPx activity was measured using a GPx activity kit (Sigma) 
according to manufacturer’s instructions. Methionine-S-sulfoxide reductase (MsrA) and 
methionine-R-sulfoxide (MsrB) activities were measured in an HPLC assay as described 
[186]. Briefly, 200 µg of total protein were added to a reaction mixture that was kept at 37 
°C for 30 min in the presence of 20 mM DTT and either 200 µM dabsyl-methionine-S-
sulfoxide (to assay for MsrA activity) or 200 µM dabsyl-methionine-R-sulfoxide (to assay 
for MsrB activity). After stopping the reaction by adding 200 µl acetonitrile, it was 
centrifuged at 4 °C for 15 min at 13,000 rpm and the supernatant (50 µl) was injected onto 
a C18 column (ZORBAX Eclipse XDB-C18) to quantify the resulting dabsylated 
methionine. 
Splenocyte isolation and 75Se metabolic labeling. After dissection, spleen was 
immediately transferred into ice-cold DMEM and mashed through a 45 µm cell strainer 
into the 50 ml tube. Cells were centrifuged at 800 g for 5 min. The pellet was resuspended 
in 5 ml of ASK buffer (GIBCO) and incubated at room temperature for 5 min. Cells were 
then diluted with DMEM and pelleted at 800 rpm for 5 min. The resulting pellet was 
resuspended in 15 ml DMEM supplemented with 10% fetal bovine serum (GIBCO), 
Antibiotic/Antimicotic (GIBCO), 0.4 mM glutamine and freshly neutralized 75Se selenious 
acid (specific activity 1000 Ci/mmol, final concentration in the medium 1 nM), and pooled 
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into a 15 cm plate. After 24 h, cells were washed 3 times with ice-cold PBS, and lysed in 
CellLytic buffer (Sigma). Protein extracts were analyzed by SDS-PAGE followed by 
autoradiography.  
Whole transcriptome sequencing and assembly of selenoprotein genes. 
Extraction of the total RNA from MR liver was carried out using a RNAqueous kit 
(Ambion) according to the manufacturer’s instructions. DNA was removed by treatment 
with DNAse I (Ambion). Liver transcriptome was sequenced at the University of 
Nebraska-Lincoln genomic facility on an Illumina instrument. To assemble 35 bp reads 
into longer contigs, three different strategies were used. First, mapping reads to reference 
sequence from mouse or guinea pig genomes was performed using MAQ package 0.7.1 
[http://maq.sourceforge.net/]. Second, SOAP package 1.03 [http://soap.genomics.org.cn/] 
was used for de novo assembly of short reads. Finally, we employed an in-house program 
that was optimized for assembling selenoprotein genes and utilized the variety of 
information available from MAQ and SOAP output, as well as known sequences from 
other rodents. 
Inductively-coupled plasma mass spectrometry (ICP-MS). Quantitative 
analyses of trace elements in animal tissues were performed using ICP-MS. Freshly frozen 
mouse and MR tissues were homogenized and sonicated in PBS with Complete protease 
inhibitor cocktail (Roche, Basel, Switzerland) (1 tablet in 50 ml PBS). Samples were 
normalized to protein content in each lysate as determined using Bradford Protein Kit 
(Bio-Rad, Hercules, CA). Samples were digested in 15% nitric acid, 15% hydrogen 
peroxide for 2 h at 70 °C. 50 ppb gallium were added as an internal control to the digestion 
mix. After digestion, samples were diluted 10 times with deionized water and analyzed by 
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ICP-MS. Elemental analysis was performed at the University of Nebraska-Lincoln 
Spectroscopy Core Facility using an Agilent Technologies ICP-MS Model 7500ce (Santa 
Clara, CA) and an Elemental Scientific Inc. (Omaha, NE) SC4 autosampler. Each sample 
was analyzed in triplicate. The carrier and make-up gas flows were 0.95 and 0.15 L/min of 
Ar, respectively. The collision cell operated with 3.5 mL/min of H2 and 1.5 mL/min He for 
reaction/collision mode. Dwell times for all elements were 0.3 s. except 78Se, for which the 
dwell time was set at 0.9 s. Gallium (m/z = 71) was added to all samples and standards as 
an internal standard at 50 ppb.   
Expression constructs for mouse and MR GPx1 and their mutants. Mouse and 
MR GPx1 cDNAs containing the 3’-UTRs including SECIS elements were amplified by a 
two step PCR with primers that introduced Myc-tag into ORFs. Primers were designed as 
follows: mouse: 1st round, 5’-CTCAGAGGAGGATCTCTGTGCTGCTCGGCTCTCCG-
3’ and 5’-GCATACTCTAGACTGATATTCAGCACTTTATTCTTAGTAGTGAAACC-
3’, 2nd round, 5’-CTCAGAGGAGGATCTCTGTGCTGGTCGTTTGGCCGCGGCC-3’ 5’-
GCATACTCTAGACTGATATTCAGCACTTTATTCTTAGTAGTGAAACC-3’; MR: 1st 
round, 5’-CTCAGAGGAGGATCTCTGTGCTGGTCGTTTGGCCGCGGCC-3’ and 5’-
GCATACTCTAGAACACCCAGCACTTTATTAGAGGGTAATCATTTTGG-3’, 2nd 
round, 5’-GCATACTCTAGAACACCCAGCACTTTATTAGAGGGTAATCATTTTGG-
3’ and 5’-ATGACATCTCGAGATGGAGCAGAAGCTCATCTCAGAGGAGGATCTC-
3’. The PCR products were digested with XhoI and Xba and ligated into a similarly 
digested pCIneo vector. In the case of mouse GPx1, an early premature stop codon was 
introduced using site-directed mutagenesis with QuikChange kit (Stratagene) and primers 
5’-GAAACCCTGCTGTCCTAGCAGTCTGGCAAC-3’ and 5’-
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GTTGCCAGACTGCTAGGACAGCAGGGTTTC-3’. The resulting mutant was 
designated as the M-short form. To rescue the early stop codon in MR GPx1, we 
performed site-directed mutagenesis with primers 5’-
AAGCCCTACTCACTCAGGGGCGCGGCCCTG-3’ and 5’-
CAGGGCCGCGCCCCTGAGTGAGTAGGGCTT-3’, and the resulting mutant was 
designated as the MR-long form. To obtain cysteine mutants of mouse and MR GPx1, we 
used site directed mutagenesis with primers 5’-TCGCGTCTCTCTGCGGCACCACGAT-
3’ and 5’-ATCGTGGTGCCGCAGAGAGACGCGA-3’ for mouse GPx1, and 5’-
GAATGTGGCATCCCTCTGCGGCACCACGGTC-3’ and 5’-
GACCGTGGTGCCGCAGAGGGATGCCACATTC-3’ for MR GPx1. To obtain a 
pBudGE/GFP construct, EGFP was amplified from pEGPFN3 vector with primers 5’-
ATGACAAGCTTATGGTGAGCAAGGGCGAGG-3’ and 5’-
GGACATTCTAGATTACTTGTACAGCTCGTCC-3’. The resulting PCR product was 
ligated into a similarly digested pBudCE4.1 vector. Mouse and MR GPx1 mutants were 
amplified from pCIneo constructs with primers 5’-
GGTACCATGGAGCAGAAGCTCATCTCAGAGG-3’, 5’-
GCATACGCATACAGATCTCTGATATTCAGCACTTTATTCTTAG-3’ and 5’-
GGTACCATGGAGCAGAAGCTCATCTCAGAGG-3’, 5’-AGATCTACACCCAGCAC-
TTTATTAGAGG-3’ respectively. Cys mutants were amplified with 5’-
GGTACCATGGAGCAGAAGCTCATCTCAGAGG-3’ and 5’-
GCATACAGATCTTTAGGAGTTGCCAGACTGC-3’ (mouse) and 5’-
GGTACCATGGAGCAGAAGCTCATCTCAGAGG-3’ and 5’-
GCATACAGATCTCTATGCAGGGCCGCGCCCC-3’ (MR), and inserted into the vector 
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without the 3’-UTR. To express mouse and MR GPx1 mutants in a bacterial expression 
system, GPx1 mutants were amplified with primers 5’-
ATGCATCATATGGAGCAGAAGCTCATCTCAGAGG-3’ and 5’-
GCATGCTCGAGTTAGGAGTTGCCAGACTGC-3’ (mouse) and 5’-
ATGCATCATATGTGTGCTGGTCGTTTGGCCG-3’ and 5’-GCATG 
CTCGAGCTATGCAGGGCCGCGCCCC-3’ (MR) and cloned into pET28a expression 
vector at NdeI and XhoI sites.  
To clone mouse and MR GPx1 into pSelExpress1 (described in [187]), mouse and 
MR GPx1 coding sequences were amplified with 5’-
ATGACATAAGCTTATGGAGCAGAAGCTCATCTCAGAGG-3’ and 5’-
GCATACTCTAGATTAGGAGTTGCCAGACTGC-3’ (mouse) and 5’-
ATGACATAAGCTTATGGAGCAGAAGCTCATCTCAGAGG-3’ 5’-
GCATACTCTAGACTATGCAGGGCCGCGCCCC-3’ (MR) primers, digested with 
HindIII and XbaI restriction endonucleases and ligated into pSelExpress1 vector. To swap 
mouse and MR 3’-UTRs, we prepared the corresponding constructs on the basis of the 
pBudCE4.1/GFP vector, which expressed Myc-tagged GPx1 and GFP from separate sites 
in the construct.  
Cell culture, transfections, metabolic labeling, immunoprecipitation and 
western blot analyses. HEK 293 and HeLa cells were cultured in DMEM supplemented 
with 10% FBS, 100 units/mL penicillin, and 100 units/mL streptomycin. All transfections 
were performed with Lipofectamin transfection reagent (Invitrogen), according to the 
manufacturer’s manual. Eighteen hours after transfection, medium was replaced with the 
one containing freshly neutralized 75Se selenious acid (specific activity 1000 Ci/mmol, 
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final concentration in the medium 1 nM). Cells were labeled for 24 h and cellular extracts 
analyzed by SDS-PAGE followed by autoradiography. For immunoprecipitation, HEK 293 
cells were grown on 10 cm plates, transfected with various GPx1 constructs and 
metabolically labeled with 75Se. Cells were resuspended in PBS, supplemented with 
protease inhibitor cocktail (Sigma) and treated with a tissue homogenizer. 600 µg of total 
protein were subjected to immunoprecipitation with the Protein G Immunoprecipitation Kit 
with mouse anti-Myc antibodies (Invitrogen), according to the manufacturer’s instructions. 
For western blot analyses, samples were separated on 10% Bis-Tris gels, transferred onto 
PVDF membranes, and incubated with mouse anti-Myc (Invitrogen) or anti-GFP (Sigma) 
antibodies.  
RNA isolation and quantitative PCR. To compare GPx1 expression levels in 
mice and MRs, total liver RNA was isolated by TRIZOL extraction according to the 
manufacturer’s instructions. Genomic DNA was removed using a DNA removal kit 
(Ambion). RNA concentration was measured spectrophotometrically and cDNA was 
obtained with Superscript III Reverse Transcriptase (Invitrogen) using the oligo dT primer. 
Real time PCR was performed using a Fast SYBR Green Master Mix (Applied 
Biosystems). Primer sequences for the GPx1 expression analysis were as follows: mouse, 
5’-CAGGAGAATGGCAAGAATGAAG-3’ and 5’-GAAGGTAAAGAGCGGGTGAG-
3’; and MR, 5’-GACACCAGGAAAACGCAAAG-3’ and 
AAGGTGAAGAGCGGATGTG (primers were based on the assembled transcriptome 
sequences). GPx1 expression was normalized to that of aldolase. Primers for aldolase 
expression were as follows: mouse, 5’-GTGATCCTTTTCTACGAGACCC-3’ and 5’-
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ACCACAATTCCCTTCTCCTTG-3’; and MR, 5’-AAGATGGGTGTGACTTTGGG-3’ 
and 5’-GGTACTAGCCCATTCTGTTGAC-3’.  
Additional analyses of mRNAs. RNA was isolated from cells transfected with 
various GPx1 constructs inserted into pBudCE/GFP vector. It was then treated with 
RNAse free DNAseI (Fermentas). The resulting RNA samples were reverse transcribed 
with a SuperScript VILO cDNA synthesis kit (Invitrogen). Quantitative PCR was 
performed using a Fast SYBR Green Master Mix (Applied Biosystems). To distinguish 
recombinant GPx1 from the endogenous form, we used the direct primer specific for Myc-
tag (5’-TCATCTCAGAGGAGGATCTC-3’) and reverse primers as follows: 5’-
TGAGCCTTCTCACCATTCACTTCG-3’ (mouse) and 5’-
CGAGCACTACCAGGCCTCTGG-3’ (MR). Expression of GPx1 mutants was normalized 
to EGFP expressed from the same vector. Primers for EGFP were as follows: 5’-
TCAAGGACGACGGCAACTAC-3’ and 5’-TTGTGCCCCAGGATGTTGCC-3’. 
Protein isolation and activity assays. Recombinant cysteine GPx1 mutants were 
expressed in BL21(DE3) cells (Novagen). E. coli cells were transformed with various 
GPx1 constructs and the cells grown until an OD of 0.6 at 600 nm. Protein expression was 
induced overnight with 1 mM IPTG. Cells were harvested by centrifugation, homogenized 
in 50 ml of PBS supplemented with Protease Inhibitor Cocktail EDTA-free (Roche) and 
sonicated on ice for 20 min. The suspension was centrifuged at 9,000 rpm and the resulting 
lysates were assayed for protein concentration and fractioned on TALONTM column 
(Clontech). Fractions containing GPx1 mutants were dialyzed against PBS and subjected 
to activity assays using a GPx kit (Sigma). 
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4.4 Results 
Low levels of Se in MR tissues. We analyzed the levels and distribution of Se in 
various tissues of MR, H. glaber. Mouse tissues were used for comparison as mice are 
rodents of similar size. Paraffin-embedded tissue sections were first imaged using 
synchrotron XFM. Se was uniformly distributed in liver (Fig 17A), heart and lung tissues 
in both organisms. Mouse testes are known to accumulate Se in elongating spermatids 
[188]. However, such Se enrichment was not observed in MR testes (Fig 17B). Most MR 
tissues had considerably lower Se levels (30-75% lower). However, MR and mouse brain 
samples had similar Se contents. Brain is known to retain Se during deficiency [128].  
To verify the XFM observation of low Se in MR tissues, we measured Se in MR 
and mouse tissues using ICP-MS. All MR tissues analyzed, except brain, had lower Se 
levels than the corresponding mouse tissues (Fig 17C). The major Se pool in mice is in the 
liver; however, MR liver had low amounts of Se. Thus, MR is characterized by apparent 
Se deficiency.  
Low GPx activity in MR tissues. Since Se mostly occurs in the form of Sec in 
proteins, the low Se in MR tissues suggested a decreased expression of selenoproteins. To 
test this hypothesis, we assayed methionine sulfoxide reductase and GPx activities. 
Mammals have three MsrBs including the selenoprotein MsrB1, which is the major MsrB 
in mouse liver [16]. Since it is responsible for MsrB activity in the cytosol and nucleus 
(MsrB2 and MsrB3 are mitochondrial and endoplasmic reticulum proteins, respectively), it 
is likely the main MsrB in all mammals. MsrB1 expression and activity (as well as total 
MsrB activity) depend on dietary Se. Mammals also have a single MsrA, which is not a 
selenoprotein. We found that both MsrA and MsrB activities were similar in mice and 
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MRs (Fig 18A, B). Thus, low Se in MR tissues cannot be explained by uniform 
selenoprotein deficiency. 
GPx1 is a major mammalian GPx, which is, like MsrB1, easily regulated by dietary 
Se. We found extremely low GPx activity in MR liver compared to the corresponding 
mouse tissue (Fig 18C). Low Se in the liver correlated with low GPx activity, which was 
suggestive of low GPx1 expression. 
Sequencing and analysis of the MR liver transcriptome. Several rodent genomes 
were sequenced in recent years, but the genome of MR is not available. To characterize 
selenoprotein occurrence in MRs, we performed sequencing of the MR liver transcriptome 
using Illumina technology. Overall, 25,011,515 36-bp-long reads were obtained and 
assembled into contigs. The length distribution of assembled contigs is shown in Fig 19A. 
The best results were obtained using k-mer size of 23, wherein 395,038 contigs were 
generated, with 40,073 contigs longer than 100 bp, and 379 contigs exceeding 1,000 bp.  
Occurrence of selenoprotein genes was then examined, and we detected 15 
selenoprotein sequences. This analysis suggested that the MR selenoproteome is similar to 
that of other mammals. Schematic representation of the human selenoproteome (which 
contains 25 selenoproteins) is shown in Fig 19B, with MR orthologs identified in the 
current study highlighted. The lack of some selenoprotein genes was likely due to 
insufficient sequencing depth, but it also could be an indicator of their low expression in 
MR liver. Overall, even though Se levels and GPx activity were low in MR liver, this 
organ expressed many selenoprotein mRNAs, and the majority of these sequences had no 
unusual features. 
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SelP is the only mammalian selenoprotein that contains more than one Sec and it 
has two SECIS elements in the 3’-UTR. Mammalian SelPs generally have 10-15 Sec 
residues, e.g., 10 Sec in human, mouse and rat SelPs [38]. However, we found only 7 Sec 
residues in MR SelP (Fig 20). Together with SelP from Cavia porcellus, this is the lowest 
Sec content of any vertebrate SelP.  
In addition, we detected an unusual feature in MR GPx1: an early stop codon 
present 5 codons upstream of the position terminating GPx1 synthesis in other mammals 
(Fig 19C, 21). Thus, MR GPx1 was predicted to be 5 amino acids shorter than other 
mammalian GPx1s. SECIS elements in MR selenoprotein genes satisfied the requirements 
of a canonical eukaryotic SECIS model. Overall, it is likely that the MR selenoproteome is 
not significantly different from that of other mammals, with the exception of SelP and 
GPx1 sequences. 
Low GPx1 expression in MR. To test for GPx1 expression levels, we isolated 
mouse and MR splenocytes, metabolically labeled the cells with 75Se and they were 
analyzed by SDS-PAGE followed by autoradiography (Fig 18D). It appeared that the 
GPx1 band was missing in MR splenocytes. To test if low GPx1 expression and activity 
were due to a low mRNA expression, GPx1 mRNA levels were examined by real-time 
PCR. We found that the MR GPx1 mRNA was expressed at much lower levels than mouse 
GPx1 mRNA in the liver (Fig 18E). Thus, the low GPx1 activity was, at least in part, due 
to low GPx1 mRNA levels.  
Reduced expression of MR GPx1 in transfected mammalian cells. An early stop 
codon in MR GPx1 could also contribute to the low expression and activity of GPx1. To 
test this possibility, we prepared constructs containing MR GPx1 with the early UAG stop 
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codon, and the one, where UAG was replaced with CAG (encoding glutamine present in 
mouse GPx1 at this position). As a control, we prepared mouse GPx1 and its mutant, in 
which the CAG codon was changed to UAG (Fig 22A). The constructs were transfected 
into HEK 293 cells, which were then labeled with 75Se and analyzed for selenoprotein 
expression patterns (Fig 22C, upper panel). The same membrane was also subjected to 
western blot analysis with anti-Myc antibodies (Fig 22C). To distinguish from the 
endogenous GPx1, proteins were immunoprecipitated with anti-Myc antibodies and 
analyzed on a gel (Fig 22C, lower panel). Expression levels of MR GPx1 were much lower 
than that of mouse GPx1. Introduction of CAG in place of UAG further decreased MR 
GPx1 expression. At the same time, substitution of CAG with UAG in mouse GPx1 did 
not decrease GPx1 expression.  
In addition, mouse and MR GPx1 forms were cloned into a pBudCE4.1 vector, 
containing GFP under CMV promoter. In further experiments, GFP was used as an internal 
control for transfection and protein loading. Inhibition of proteasome in HEK 293 cells did 
not rescue MR GPx1 expression (Fig 22D). In addition, real time PCR analysis revealed no 
difference between mouse and MR GPx1 mRNA after transfection (Fig 22B). Thus, MR 
GPx1 expression was suppressed regardless of the early stop codon. However, substitution 
of Sec with cysteine partially rescued expression of MR GPx1 (Fig 22E). These data 
suggest that incorporation of Sec may limit GPx1 synthesis. We also checked if the early 
stop codon in MR GPx1 affects peroxidase activity of this enzyme by expressing Cys-
containing His-tagged MR and mouse GPx1s in bacteria. These mouse and MR GPx1 
proteins had similar activities (Fig 23). These data suggest that the early stop codon neither 
affects expression nor activity of the enzyme, and that the low expression of MR GPx1 is 
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due to a combination of low mRNA levels and decreased Sec insertion. These two factors 
may be linked, e.g., inefficient Sec insertion may destabilize GPx1 mRNA. 
SECIS element in MR GPx1 is not responsible for low GPx1 expression. Sec 
insertion includes recognition of the SECIS element in the 3’-UTR of selenoprotein 
mRNAs by SBP2 and subsequent recruitment of additional factors, such as EFSec and 
tRNASec[Ser], which insert Sec in response to the UGA codon. Efficiency of Sec 
incorporation may depend on additional features, such as the position of the UGA codon 
within the ORF and the type of SECIS element. Alignment of GPx1 SECIS elements 
revealed a nucleotide substitution in the conserved SBP2 binding site (Fig 24A). However, 
comparison of MR (Fig 24B) and mouse (Fig 24C) SECIS elements in GPx1 did not show 
unusual features in the MR SECIS element, suggesting that the predicted structure may 
support Sec incorporation.  
To directly test if the MR GPx1 SECIS element is responsible for the low GPx1 
expression, we cloned coding sequences of mouse and MR GPx1s into pSelExpress1 
vector containing a highly efficient eukaryotic SECIS element [187]. Analysis of these 
expression constructs (containing the same SECIS element) by metabolic 75Se labeling of 
transfected HEK 293 cells showed that the MR GPx1 was still expressed at a low level 
compared to mouse GPx1 (Fig 24D). To further examine the role of SECIS elements as 
well as the entire 3’-UTRs in GPx1 expression, we prepared constructs that swapped the 
3’-UTRs between mouse and MR GPx1s. These constructs were expressed in HEK 293 
cells, followed by 75Se labeling and Western blot analysis (Fig 24E). Substitution of the 
MR GPx1 3’-UTR with the mouse one did not increase MR GPx1 expression; in addition, 
replacement of the mouse GPx1 3’-UTR with the MR one did not decrease the expression 
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of mouse GPx1. Thus, neither SECIS element nor the 3’-UTR were responsible for the 
reduced MR GPx1 expression. It is an attractive possibility that the overall GPx1 mRNA 
structure modulates the rate of Sec incorporation. 
Absence of GPx1 decreases Se levels in mice. GPx1 is the most abundant 
selenoprotein in mouse liver and kidney. We tested if removal of this protein could affect 
Se levels in tissues by examining WT and GPx1 knockout mice. Se levels in GPx1 
knockout mice were almost twice lower than those in WT livers (Fig 25) (p = 0.00387) and 
kidneys (p = 0.0409). However, in tissues characterized by lower GPx1 levels, such as 
spleen, heart, lung, and brain, Se levels were not affected by GPx1 knockout. Thus, the 
absence of GPx1 could indeed be responsible for the reduced Se use by MRs.  
GPx1 expression in long lived rodents. To examine if the aberrant expression of 
MR GPx1 has evolutionary aspects, we analyzed its levels in primary skin fibroblasts 
derived from long-lived rodents, including white footed mouse, chipmunk, vole, single fox 
squirrel, beaver and porcupine, and also examined fibroblasts from another long-lived 
mammal, little brown bat [189]. Cells were metabolically labeled with 75Se, and proteins 
analyzed by SDS PAGE followed by autoradiography (Fig 26). HEK 293 cells were used 
as a positive control, and mouse embryonic fibroblasts derived from GPx1 knockout mice 
as a negative control. All analyzed species, except porcupine, had a strong band 
corresponding to GPx1. In the case of porcupine, we observed a weak 75Se signal in the 
GPx1 position and a stronger band that migrated faster than GPx1. Sequence analysis of 
GPx1 in these rodents should await the availability of their genome sequences. However, 
examination of the phylogenetic tree indicated that MR and porcupine share a common 
ancestor (Fig 26B), whereas other examined mammals are more distant. Thus, it appears 
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that the defect in GPx1 expression may not be limited to MR and may occur in a subset of 
rodents. 
4.5 Discussion 
GPx1 is an abundant glutathione peroxidase in mammals. It plays an important role 
in the protection of cells from oxidative stress by reducing hydrogen peroxide with 
glutathione. Surprisingly, we found that GPx1 is essentially absent in MR tissues, while 
other selenoproteins are expressed at normal levels and/or are enzymatically competent. 
Sequencing and analysis of the MR liver transcriptome detected GPx1 mRNA, but it was 
present at low levels and had an early termination codon. Further analyses revealed that the 
low expression was likely due to a combination of low mRNA levels and decreased 
insertion of Sec rather than due to compromised GPx1 activity caused by premature 
termination.  
It was reported that GPx1 is the most abundant liver selenoprotein. In rat liver, it 
accounts for 63% of the total Se [190]. Se deficiency induces rapid degradation of GPx1 
mRNA (and several other selenoprotein mRNAs), while the expression levels of several 
additional selenoproteins are preserved under these conditions [191]. GPx1 was proposed 
as a biomarker of Se utilization, since its activity is very sensitive to Se dietary status. It 
was also suggested that GPx1 is a “Se buffer”, wherein this enzyme stores Se and provides 
this element for biosynthesis of selenoproteins during Se deficiency [192]. On the other 
hand, GPx1 knockout does not affect expression of other selenoproteins [78, 193]. This 
enzyme is also not essential: GPx1 knockout animals are viable; however, they are more 
susceptible to oxidative stress and show defects in redox signaling [194]. These data 
correlate with previously reported increases in oxidative stress parameters in MR, 
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including a low GSH/GSSG ratio, high rate of DNA oxidative damage, and increased 
protein carbonylation and lipid peroxidation [174]. Moreover, both GPx1 knockout mice 
and MRs showed abnormal blood glucose regulation [78, 193]. These mice had a normal 
fasting glucose, but reduced blood insulin levels [194, 195]. However, unlike GPx1 
knockout mice, MR also showed abnormal glucose tolerance (glucose levels remained 
elevated for prolonged periods of time) and insulin sensitivity (glucose levels immediately 
decreased upon insulin administration and remained low for prolonged periods of time) 
[176, 196]. In addition, GPx1 knockout mice had reduced islet β-cell mass in pancreatic 
tissue [195], while MR had different abundances of the four distinct types of islet cells. 
Even though the abnormal glucose regulation may be relevant to MR adaptation to its 
specific lifestyle, it could be, at least in part, due to an abnormal GPx1 function. 
Se levels in animal tissues vary depending on many factors, including the 
requirements of the organism for this trace element and the diet. Numerous studies 
reported on the role of dietary Se in human health. For example, Se deficiency may cause 
endemic cardiomyopathy (Keshan disease), liver degeneration observed in rats and pigs, 
and white muscle disease in ruminants and turkeys [184, 197]. None of the Se deficiency-
induced pathologies have been reported for MR. In this regard, it is particularly interesting 
that MRs have never been observed to develop cancer [166]. We compared trace element 
profiles in control and GPx1 knockout mice, and found a significant decrease of tissue Se 
levels in liver and kidney. Somewhat similar differences in Se levels were observed 
between mouse and MR. GPx1 is the most abundant selenoprotein, especially in liver and 
kidney, and the GPx1 knockout data suggest that this protein accounts for approximately 
half of Se in these organs.  
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We also observed significant differences in Se in spleen, lungs and testes (these 
tissues depend on Se provided by SelP). This selenoprotein is the only mammalian protein 
that contains multiple Sec residues [38]. Previously, we suggested that the number of Sec 
residues in SelP might be used as an indirect genetic marker of Se utilization [198]. In 
rodents and primates, the Sec content of SelP is almost twice as low as in aquatic 
vertebrates. Comparison of rodent SelPs shows that C. porcellus and MR SelPs have 7 Ser 
residues, which is the lowest number of SelP Sec residues in vertebrates. MR, porcupine 
and C. porcellus are closer to each other and are more distant to other rodents, such as 
mice, rats and rabbits [199]. Our analysis of GPx1 expression suggested a decreased GPx1 
expression in MR and porcupine, and previous research revealed low GPx1 activity in C. 
porcellus [200]. Overall, these data suggest a possible loss of GPx1 function in this 
specific group of rodents and, as a consequence, a reduced requirement for Se by these 
organisms. It is remarkable that such an important selenoprotein is compromised in these 
animals, which survived for tens of millions of years essentially without GPx1. 
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Figure 17. XFM and ICP-MS analysis of Se in mouse and MR tissues. XFM 
scans of mouse and MR livers (A) and testes (B). Each element and its maximum and 
minimum threshold values are given above each image in ng/cm2. The rainbow-colored 
scale bar relates to the signal intensity measured as ng/cm2 in each spot with dark pixels 
representing areas of low concentration and a gradient to bright pixels depicting increasing 
concentrations. A scale bar is shown below the elemental maps. (C) Se was analyzed by 
ICP-MS in mouse and MR tissues. Values are means +/- SD. Organs in which trace 
elements were analyzed are shown below each panel (*p<0.05). 
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Figure 18. MR tissue extracts have low GPx1 expression and activity. Total 
MsrB (A), MsrA (B) and GPx (C) activities were measured in indicated mouse and MR 
tissues. (D) Primary splenocytes derived from MR and mice were metabolically labeled 
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with 75Se and protein extracts were analyzed by SDS-PAGE followed by autoradiography. 
The band corresponding to GPx1 is shown with an arrow on the right. (E) Relative 
expression of GPx1 mRNA in MR and mouse liver (* p<0.05). 
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Figure 19. Transcriptome analysis and characterization of the MR 
selenoproteome. (A) Length distribution of assembled contigs of the MR liver 
transcriptome. (B) Selenoproteins identified in MR. The human selenoproteome is used as 
a reference to represent the MR selenoproteome. Selenoproteins identified by sequencing 
the MR liver transcriptome are highlighted. Location of Sec residues is indicated by a red 
line. Seven Sec residues were found in SelP. GPx1 has an early termination codon (see text 
for details). (C) Schematic representation of MR GPx1 in comparison with mouse GPx1. 
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Figure 20. Protein sequence alignment of SelP. The following sequences were used for 
alignment construction (Genbank accession numbers): Homo sapiens (AAH58919.1); 
Canis familiaris (NP_001108590.1); Sus scrofa (NP_001128295.1); Mus musculus 
(AAH01991.2); and Rattus norvegicus (NP_062065.2). Selenocysteine residues are 
highlighted in red, and cysteines in the positions corresponding to selenocysteine are 
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shown in blue.
 
Figure 21. Protein sequence alignment of GPx1. The following sequences were 
used for alignment construction (Genbank accession numbers): Homo sapiens 
(NP_000572.2); Sus scrofa (NP_999366.1); Canis familiaris (NP_001108591); Rattus 
norvegicus (AAB95647.2), Mus musculus (CAA27558) and Cavia porcellus 
(AAKN02012894.1). The selenocysteine residue is highlighted in red and indicated by an 
asterisk. The early stop codon in the MR sequence is also highlighted in red. 
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Figure 22. GPx1 is poorly expressed in mammalian cells. (A) Schematic 
representation of MR and mouse GPx1 mutant constructs. Positions of Sec and glutamine 
(CAG) codons, the stop signal (TAG) and the SECIS element in the 3'-UTR are shown. (B) 
mRNA levels were assessed by real time PCR and normalized to GFP expressed from the 
same vector. Results are given +/- SD. (C) MR and mouse Myc-GPx1 constructs were 
transfected into HEK 293 cells. Cells were labeled with 75Se followed by SDS-PAGE and 
autoradiography (upper panel). Migration of ectopically expressed GPx1 is shown on the 
left. Same lysates were probed with anti-Myc and anti-β-actin antibodies (two bottom 
panels). Myc-GPx1 mutants were also immunoprecipitated with anti-Myc antibodies, 
followed by PhosphorImager analysis of the 75Se-labeled GPx1. (D) Mouse and MR 
constructs were transfected into HEK 293 cells followed by treatment of cells with 10 µM 
MG132 for 12 h. Cells were labeled with 75Se followed by protein analysis by SDS-PAGE 
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and autoradiography (upper panel). The same membrane was stained with Myc and GFP 
antibodies. (E) Expression of mouse and MR cysteine mutants of GPx1 in HEK 293 cells 
was analyzed by Western blotting. IP, immunoprecipitation. WB, western blotting. 
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Figure 23. Expression of mouse and MR GPx1 in E. coli. Cysteine mutants of 
MR and mouse GPx1 were cloned into pET28a and expressed in E. coli. (A) Proteins were 
isolated from identical amounts of bacterial culture and aliquots were analyzed by SDS-
PAGE. (B) Glutathione peroxidase activity of MR and mouse GPx1 was measured and 
normalized to the amount of protein in each sample. Results are given +/- SD. 
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Figure 24. SECIS element does not decrease GPx1 expression level. (A) 
Aligment of mammalian GPx1 SECIS elements. Nucleotides critical for the SECIS 
function are underlined. (B) MR GPx1 SECIS element as predicted by SECISearch. 
Functional sites are shown in bold. (24). (C) Mouse GPx1 SECIS element. Functional sites 
are shown in bold. (D) Mouse and MR GPx1 coding sequences were cloned into 
pSelExpress1 containing an efficient eukaryotic SECIS element and expressed in HEK 293 
cells. Cells were labeled with 75Se followed by SDS-PAGE, autoradiography and Western 
blotting with Myc antibodies. Coomassie staining is a loading control. (E) Coding 
sequences of mouse GPx1 containing the MR GPx1 3’-UTR (M-long-MR SECIS) and 
coding sequence of MR GPx1 containing mouse GPx1 3’-UTR (MR-short-M SECIS) were 
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expressed in HEK 293 cells. Cells were labeled with 75Se followed by SDS-PAGE, 
autoradiography and Western blotting with Myc and GFP antibodies. 
 
 
Figure 25. Reduction in Se levels in tissues of GPx1 KO mice. Se was 
determined by ICP-MS in tissues from wild type (WT) and GPx1 knockout (KO) mice. 
Values are means +/- SD. Organs in which Se was analyzed are shown below each panel 
(** p<0.005, *p<0.05). 
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Figure 26. Expression of GPx1 in skin fibroblasts of rodents and long lived 
mammals. (A) Cells were labeled with 75Se followed by SDS-PAGE and autoradiography. 
HEK 293 cells and MEFs derived from GPx1 KO mice were used as positive and negative 
controls, respectively. Migration of the band corresponding to GPx1 is shown with an 
arrow. (B) Schematic representation of the phylogenetic tree of rodents (adapted from 
[199]). 
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CHAPTER 5 
Conclusions and future directions 
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5.1 Roles of trace elements in regulation of the gastrointestinal 
microbiome 
Our results indicate the importance of the trace element Se in regulation of the 
gastrointestinal microflora. Dietary Se increased diversity of microflora and differentially 
affected various groups of microorganisms. These effects were more pronounced in 
conventionalized mice, which might be explained by the fact that the contribution of the 
pre-existing microflora was removed. The observed differential sensitivity to dietary Se 
might be due to differences in Se utilization pathways among microorganisms [201]. On 
the other hand, our study demonstrates that the intestinal microflora is an essential 
intermediate between dietary Se and the host selenoproteome. This observation leads to 
several questions that might be addressed in future studies. First, intestinal microflora 
plays an important role in protecting a rapidly renewing intestinal epithelium from various 
pathological processes, such as through induction of Toll like receptor (TLR) mediated 
signaling. Induction of this pathway is critical in protecting intestinal cells from apoptosis, 
which might be induced by exogenous injury or pathogenic infection [202]. At the same 
time, GPx1 and GPx2 play a role in protecting intestinal cells from oxidative stress and 
their removal is associated with severe pathology [203, 204]. Thus, a better understanding 
of Se distribution between the host and microbiota may explain the beneficial role Se 
supplementation under certain conditions. Second, it would be important to follow the 
effect of Se-modified intestinal microflora on health parameters, which depends on 
intestinal microflora, such as susceptibility to IBD, various intestinal infections, food 
digestion and obesity. These experiments might be carried out using similar models we 
applied in our study. Intestinal microflora in GF mice can be reestablished by intestinal 
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extracts obtained from Se-deficient and Se sufficient mice. Finally, the observed effects 
might not be limited just for Se. Other trace elements, such as Cu, Fe, Mn and Zn may also 
play an important role in regulation of the intestinal microflora, and it might be an 
interesting field in nutritional studies. Se has been the first trace element for which the role 
of microbiota has been addressed, and these studies should be extended to other trace 
elements.  
 
5.2 Function of Sep15 in cataract formation 
In our study, we characterized Sep15 KO mice and found them to consistently 
develop nuclear cataracts. However, the underlying mechanism is still unclear. In addition, 
Se-deficient mice (that are maintained on the Se deficient diet for one year) were not found 
to develop cataracts (unpublished results). Sep15 participates in the glycoprotein folding 
cycle, and Sep15 mRNA is enriched during lens development. One of possible 
explanations of the nuclear cataracts, observed in the Sep15 KO mice, is the improper 
folding of Sep15 targets, which may play a role in maintenance of lens integrity and 
transparence. The next step in our understanding of Sep15 function in cataract formation 
will be the identification of Sep15 targets in lens epithelial cells. To identify Sep15 targets, 
we will apply in vivo target search model, since Sep15 is characterized by thioredoxin-like 
fold and has a redox motifs, UxC (U is Sec). We will take advantage of the previously 
developed reaction mechanism of this class of enzymes. One of Cys in the redox motif 
serves as a nucleophilic attacking group, leading to the formation of a covalently-linked 
intermediate. The other Cys has a resolving function: it releases the reduced product and 
forms an intramolecule disulfide. A stardard approach to trap the substrates of thiol 
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oxidoreductases is to mutate the resolving Cys to serine, that would allow a formation of 
the intermolecular intermediate, but would prevent substrate release (Fig 27). We will 
employ this approach to trap Sep15 targets and further sequence then by mass 
spectrometry. Introduction of FLAG and HA tags on N- and C-termini will allow us to 
perform large scale purification using FLAG/HA tandem purification kit, designed by 
Sigma, i.e., I.P for one tag followed by Western blot identification with antibodies for 
another tag. These mutants will be prepared in a vector that allows efficient expression in 
mammalian cells. Previously, a similar approach was applied for Drosophila Sep15, which 
contains a Cys in place of Sec. When such redox-inactive mutants were purified from 
insect cells and immobilized on the column, no targets were identified. A possible 
explanation is that, for proper function, Sep15 needs to be localized in the ER and/or 
interact with UDP glucose:glycoprotein glucosyltransferase. To examine the interactions 
under more natural conditions, we will express Sep15 (Fig 27B) in lens epithelial cells. 
The Sep15 mutant proteins will contain the HA tag upstream of the ER-targeting signal 
and the FLAG tag at the C-terminus. In SelM (homolog of Sep15) mutants, the FLAG tag 
will be inserted upstream of the ER retention signal. Then, we will perform 
immunoprecipitation with anti-HA antibodies. Samples will be applied to SDS-PAGE 
under non-reducing conditions. This will allow us to identify mixed disulfides by Western 
blotting with anti-FLAG antibodies. Later, the I.P. samples will be reduced with 10 mM 
DTT, separated by SDS-PAGE, stained with Coomassie blue, and subjected to mass 
spectrometry analyses. Targets identified during thus procedure will be verified in 
subsequent in vitro experiments, and the interactions will be confirmed in a cell culture 
system by co-immunoprecipitation. Both Cys- and Sec-containing versions of 
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selenoproteins will be used. These proteins will be co-transfected into mammalian cells, 
selenoproteins will be immunoprecipitated with antibodies against the tag, and the samples 
will be probed with antibodies against the tag in the target protein, and, if available, against 
the target protein itself. 
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Figure 27. Experimental design for identification of substrates of Sep15. (A) 
The active site of the thioredoxin-like fold protein Sep15 includes a CxU motif. In the CxU 
motif, one residue (Sec) is the attacking residue, whereas the other residue (Cys) likely 
completes the reaction by resolving the intermolecular disulfide. (B) The mutants of Sep15 
designed for the in vivo target search experiment.  
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5.3 Reduced utilization of Se by long lived animals 
In our study, we found low levels of Se in MR tissues. Such reduced utilization of 
Se can be explained by the low levels of the major mammalian selenoprotein, GPx1. 
However, the exact reason for such dramatic reduction in expression is still unclear. We 
examined several hypotheses, including the role of the premature stop codon and an 
atypical SECIS structure; however, these factors did not explain the observed low 
expression of GPx1. Interstingly, substitution of Sec with Cys rescued GPx1 expression, 
by increasing the rate of translation. One additional hypothesis is associated with the 
presence of rare codons in the sequence of the MR GPx1. The analysis of GPx1 expression 
in long lived mammals, demonstrated the low expression of GPx1 in the porcupine. 
Porcupine, MR and guinea pig are in the same branch of the evolutionary tree. Thus, 
analysis of expression of porcupine and guinea pig GPx1 may be predicted to be low as 
well. If so, comparison of the sequences of MR, porcupine and guinea pig GPx1 can reveal 
common features (e.g., rare codons), that drastically decrease protein expression. Such 
studies may help identify novel mechanisms of regulation of protein expression at the 
translational level. 
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